Protocol - International Travel History

Description

From the Global Surveillance Network of the International Society of Travel Medicine (ISTM) and the Centers for Disease Control and Prevention (CDC), The GeoSentinel protocol is a self-reported questionnaire that collects information on a respondents recent (within the last 6 months) and previous (within the last 5 years) travel history. It also provides a template for the clinician to use in assessing the exposure details.

Specific Instructions

Updates to the date ranges within the protocol will need to be made to collect accurate data based on the start date of future studies.

For Sections 2 and 3, if the respondent has more travel information than the allotted space allows, please collect that information as well.

Availability

Available

Download PDF

Protocol

1. General Information		Gender [ ] Male [ ] Female	Age	*Todays Date Month/Day/Year (Clinic Visit Date)
*Country of Birth				Primary Country of Residency Before Age 10
*Country of Citizenship				*Country of Current Residence
[ ] Immigrant	If you were not born in USA, indicate as Month/Day/Year closely as possible the date you first arrived here:

2. History of Recent Travel			List in order, starting with the most recent trip, all international travel in the past 6 months. Using 1 line for each separate trip, list each country visited during that trip. Indicate if the trip included travel on a ship.
Trip	*Trip Start Date Month/Day/Year	*Trip End Date Month/Day/Year	*Country 1	*Country 2	*Country 3	*Country 4	*Country 5
1
2
3
4
5
6

3. History of Previous Travel

List all countries visited or resided in over the past 5 years (exclude country of current residence and travel in the past 6 months listed above). 1. List each country only once. 2. CHECK the year(s) of travel to that country. 3. CHECK the box below the year if any stay in that country in that year was longer than 30 consecutive days.

*Country:

*Check each year of travel to the country

[ ]
2009

[ ]
2008

[ ]
2007

[ ]
2006

[ ]
2005

[ ]
2004

[ ]
2009

[ ]
2008

[ ]
2007

[ ]
2006

[ ]
2005

[ ]
2004

[ ]
2009

[ ]
2008

[ ]
2007

[ ]
2006

[ ]
2005

[ ]
2004

Check if stay was >30 consecutive days

[ ]

*Country:

*Check each year of travel to the country

[ ]
2009

[ ]
2008

[ ]
2007

[ ]
2006

[ ]
2005

[ ]
2004

[ ]
2009

[ ]
2008

[ ]
2007

[ ]
2006

[ ]
2005

[ ]
2004

[ ]
2009

[ ]
2008

[ ]
2007

[ ]
2006

[ ]
2005

[ ]
2004

Check if stay was >30 consecutive days

[ ]

PATIENT SHOULD NOT COMPLETE THIS PAGE—TO BE COMPLETED BY CLINICIAN ONLY

Country of Exposure >5 years ago: If a country of exposure that is related to a Final Diagnosis for the current illness was visited more than 5 years ago, add that country to the history of previous travel (section 3) and indicate that travel there occurred >5 years ago (use the notation <2003).

4. Exposure Details

*Country of Exposure/Other (Check the applicable box and/or enter up to 2 countries. The country[s] where the current illness as defined by the final diagnosis was to a high degree of certainty acquired. A single country of exposure is the preferred standard. However, 2 countries may be designated if the likelihood of exposure is almost equal amongst the 2 countries. Exposure Country Not Ascertainable should be selected for situations where it is not possible to attribute Country of Exposure.):

[ ] Exposure Country Not Ascertainable [ ] Ship [ ] Plane

Country
1: _____________________________ Country
2: ____________________________

More Specific Place of Exposure (below level of country; i.e., city, state, location, event; leave blank if 2 countries are listed above):

*Reason for Travel Related to Current Illness (Check One):

[ ] Tourism

[ ] Business

[ ] Missionary/Volunteer/

Researcher/Aid Work

[ ] Student

[ ] Medical Tourism

[ ] Immigration

[ ] Visiting Friends & Relatives

[ ] Military

Risk Level Qualifier (Check One): [ ] Pre-Arranged or Organized Travel [ ] Risk Travel
[ ] Expatriate

*Clinical Setting (Check One): [ ] Seen During Travel [ ] Seen After Travel
[ ] Immigration Travel Only

*Patient Type(Check One): [ ] Inpatient [ ] Outpatient [ ] TeleConsult-Outpatient
[ ] TeleConsult-Inpatient

Did the patient have a pre-travel encounter with a health care provider? (Check One):
[ ] Yes [ ] No [ ] Dont Know

*Main Presenting Symptoms (Check at least one symptom below, but include all symptoms that apply):

[ ] Abnormal Lab Test	[ ] Asymptomatic Screening	[ ] Cardiac	[ ] Fatigue
[ ] Fever	[ ] Gastrointestinal	[ ] Genitourinary	[ ] HEENT
[ ] Lymphatic	[ ] Musculoskeletal	[ ] Neurologic	[ ] Psychologic
[ ] Respiratory	[ ] Skin
[ ] Other If "Other," Specify: ____________________________________________________

5. Diagnoses

Dx#

Working Diagnosis

Working Dx Status (circle one)

*Final Diagnosis

*Final Dx Status (circle one)

C P S E CT PT ST

C P S

C P S E CT PT ST

C P S

C P S E CT PT ST

C P S

C P S E CT PT ST

C P S

C P S E CT PT ST

C P S

Dx Status Legend: C = Confirmed; P = Probable; S = Suspected; E = Exclusion of;
CT, PT, ST = Status Post (Confirmed, Probable, Suspected)

[ ] Not Travel Related Check this box if patient was primarily diagnosed with an infection or disease that was acquired or existed at home prior to departure or which was acquired after travel but prior to the clinic visit. If Not Travel Related is checked, Main Presenting Symptoms are still required; however, all other fields in the Exposure Details section are optional, but they should be answered as related to the reason for clinic visit and not related to the current illness.

Dx Diagnosis
* = These items are required fields for successful online data entry. Note: Sections 2 and 3 may be omitted if not applicable.

Personnel and Training Required

A health professional to diagnose diseases and conditions is required to complete Sections 4 and 5 of the questionnaire.

Equipment Needs

Either a paper-and-pencil or computer-assisted instrument may be used. If a computer-assisted instrument is used, computer software may be necessary to develop the instrument.

Requirements

Requirement Category	Required
Major equipment	No
Specialized training	Yes
Specialized requirements for biospecimen collection	No
Average time of greater than 15 minutes in an unaffected individual	No

Mode of Administration

Self-administered questionnaire and clinical assessment

Lifestage

Adult

Participants

Adults, aged 18 years and older

Selection Rationale

The GeoSentinel questionnaire was selected because it is recognized as a worldwide system for communication and collection of data on morbidity due to travel-related infection. It includes a protocol based on available current research that is valid and reliable and that is associated with disease outcomes.

Language

English

Standards

Standard	Name	ID	Source
Logical Observation Identifiers Names and Codes (LOINC)	International travel hx proto	62888-3	LOINC
caDSR Form	PhenX PX161201 - International Travel History	6257520	caDSR Form

Derived Variables

None

Process and Review

Not applicable.

Protocol Name from Source

Centers for Disease Control and Prevention (CDC), GeoSentinel Questionnaire, 2008

Source

International Society of Travel Medicine (ISTM) and the Centers for Disease Control and Prevention (CDC). 2008 GeoSentinel Questionnaire. Sections 1–5.

General References

None

Protocol ID

161201

Variables

Export Variables

Variable Name	Variable ID	Variable Description	dbGaP Mapping
PX161201_Age
	PX161201020000	Age	Variable Mapping
PX161201_Clinical_Setting
	PX161201260000	Clinical Setting (Check One)	N/A
PX161201_Country1_Of_Exposure
	PX161201220200	Country of Exposure/Other - Country 1	N/A
PX161201_Country2_Of_Exposure
	PX161201220300	Country of Exposure/Other - Country 2	N/A
PX161201_Country_Of_Birth
	PX161201040000	Country of Birth	Variable Mapping
PX161201_Country_Of_Citizenship
	PX161201060000	Country of Citizenship	N/A
PX161201_Country_Of_Current_Residence
	PX161201070000	Country of Current Residence	Variable Mapping
PX161201_Date_Arrived_US_Day
	PX161201090200	If you were not born in USA, indicate as more closely as possible the date you first arrived here: Enter Day show less	N/A
PX161201_Date_Arrived_US_Month
	PX161201090100	If you were not born in USA, indicate as more closely as possible the date you first arrived here: Enter Month show less	N/A
PX161201_Date_Arrived_US_Year
	PX161201090300	If you were not born in USA, indicate as more closely as possible the date you first arrived here: Enter Year show less	N/A
PX161201_Date_Day
	PX161201030100	Today's Date (Clinic Visit Date) - Day	N/A
PX161201_Date_Month
	PX161201030200	Today's Date (Clinic Visit Date) - Month	N/A
PX161201_Date_Year
	PX161201030300	Today's Date (Clinic Visit Date) - Year	N/A
PX161201_Exposure
	PX161201220100	Country of Exposure/Other	N/A
PX161201_Final_Diagnosis_1
	PX161201360100	Final Diagnosis 1	N/A
PX161201_Final_Diagnosis_1_Status
	PX161201360200	Final Diagnosis 2 Status (circle one)	N/A
PX161201_Final_Diagnosis_2
	PX161201370100	Final Diagnosis 2	N/A
PX161201_Final_Diagnosis_2_Status
	PX161201370200	Final Diagnosis 2 Status (circle one)	N/A
PX161201_Final_Diagnosis_3
	PX161201380100	Final Diagnosis 3	N/A
PX161201_Final_Diagnosis_3_Status
	PX161201380200	Final Diagnosis 3 Status (circle one)	N/A
PX161201_Final_Diagnosis_4
	PX161201390100	Final Diagnosis 4	N/A
PX161201_Final_Diagnosis_4_Status
	PX161201390200	Final Diagnosis 4 Status (circle one)	N/A
PX161201_Final_Diagnosis_5
	PX161201400100	Final Diagnosis 5	N/A
PX161201_Final_Diagnosis_5_Status
	PX161201400200	Final Diagnosis 5 Status (circle one)	N/A
PX161201_Final_Diagnosis_6
	PX161201410100	Final Diagnosis 6	N/A
PX161201_Final_Diagnosis_6_Status
	PX161201410200	Final Diagnosis 6 Status (circle one)	N/A
PX161201_Gender
	PX161201010000	Gender	Variable Mapping
PX161201_Immigrant
	PX161201080000	Immigrant	N/A
PX161201_Main_Presenting_Symptoms_AbnormalLabTest
	PX161201290101	Main Presenting Symptoms (Check at least one more symptom below, but include all symptoms that apply): Abnormal Lab Test show less	N/A
PX161201_Main_Presenting_Symptoms_AsymptomaticScreening
	PX161201290102	Main Presenting Symptoms (Check at least one more symptom below, but include all symptoms that apply): Asymptomatic Screening show less	N/A
PX161201_Main_Presenting_Symptoms_Cardiac
	PX161201290103	Main Presenting Symptoms (Check at least one more symptom below, but include all symptoms that apply): Cardiac show less	N/A
PX161201_Main_Presenting_Symptoms_Fatigue
	PX161201290104	Main Presenting Symptoms (Check at least one more symptom below, but include all symptoms that apply): Fatigue show less	Variable Mapping
PX161201_Main_Presenting_Symptoms_Fever
	PX161201290105	Main Presenting Symptoms (Check at least one more symptom below, but include all symptoms that apply): Fever show less	Variable Mapping
PX161201_Main_Presenting_Symptoms_Gastrointestinal
	PX161201290106	Main Presenting Symptoms (Check at least one more symptom below, but include all symptoms that apply): Gastrointestinal show less	N/A
PX161201_Main_Presenting_Symptoms_Genitourinary
	PX161201290107	Main Presenting Symptoms (Check at least one more symptom below, but include all symptoms that apply): Genitourinary show less	Variable Mapping
PX161201_Main_Presenting_Symptoms_HEENT
	PX161201290108	Main Presenting Symptoms (Check at least one more symptom below, but include all symptoms that apply): HEENT show less	Variable Mapping
PX161201_Main_Presenting_Symptoms_Lymphatic
	PX161201290109	Main Presenting Symptoms (Check at least one more symptom below, but include all symptoms that apply): Lymphatic show less	Variable Mapping
PX161201_Main_Presenting_Symptoms_Musculoskeletal
	PX161201290110	Main Presenting Symptoms (Check at least one more symptom below, but include all symptoms that apply): Musculoskeletal show less	Variable Mapping
PX161201_Main_Presenting_Symptoms_Neurologic
	PX161201290111	Main Presenting Symptoms (Check at least one more symptom below, but include all symptoms that apply): Neurologic show less	Variable Mapping
PX161201_Main_Presenting_Symptoms_Other
	PX161201290115	Main Presenting Symptoms (Check at least one more symptom below, but include all symptoms that apply): Other show less	N/A
PX161201_Main_Presenting_Symptoms_Other_Specify
	PX161201290116	Main Presenting Symptoms If Other, Specify:	N/A
PX161201_Main_Presenting_Symptoms_Psychologic
	PX161201290112	Main Presenting Symptoms (Check at least one more symptom below, but include all symptoms that apply): Psychologic show less	N/A
PX161201_Main_Presenting_Symptoms_Respiratory
	PX161201290113	Main Presenting Symptoms (Check at least one more symptom below, but include all symptoms that apply): Respiratory show less	N/A
PX161201_Main_Presenting_Symptoms_Skin
	PX161201290114	Main Presenting Symptoms (Check at least one more symptom below, but include all symptoms that apply): Skin show less	N/A
PX161201_More_Specific_Place_Of_Exposure
	PX161201230000	More Specific Place of Exposure	N/A
PX161201_Not_Travel_Related
	PX161201420000	Check this box if patient was primarily more diagnosed with an infection or disease that was acquired or existed at home prior to departure or which was acquired after travel but prior to the clinic visit. show less	N/A
PX161201_Patient_Type
	PX161201270000	Patient Type (Check One)	Variable Mapping
PX161201_Pretravel_Encounter_Health_Care _Provider
	PX161201280000	Did the patient have a pre-travel encounter more with a health care provider? (Check One) show less	N/A
PX161201_Previous_Travel_Country1
	PX161201160100	History of Previous Travel - Country 1	N/A
PX161201_Previous_Travel_Country1_30daysFiveYearsAgo
	PX161201160800	History of Previous Travel - Country 1 - more Stay was longer than 30 consecutive days five years ago show less	N/A
PX161201_Previous_Travel_Country1_30daysFourYearsAgo
	PX161201160700	History of Previous Travel - Country 1 - more Stay was longer than 30 consecutive days four years ago show less	N/A
PX161201_Previous_Travel_Country1_30daysLastYear
	PX161201160400	History of Previous Travel - Country 1 - more Stay was longer than 30 consecutive days last year show less	N/A
PX161201_Previous_Travel_Country1_30daysThisYear
	PX161201160300	History of Previous Travel - Country 1 - more Stay was longer than 30 consecutive days this year show less	N/A
PX161201_Previous_Travel_Country1_30daysThreeYearsAgo
	PX161201160600	History of Previous Travel - Country 1 - more Stay was longer than 30 consecutive days three years ago show less	N/A
PX161201_Previous_Travel_Country1_30daysTwoYearsAgo
	PX161201160500	History of Previous Travel - Country 1 - more Stay was longer than 30 consecutive days two years ago show less	N/A
PX161201_Previous_Travel_Country1_FiveYearsAgo
	PX161201160206	History of Previous Travel - Country 1 - more Check if travelled to country five years ago. show less	N/A
PX161201_Previous_Travel_Country1_FourYearsAgo
	PX161201160205	History of Previous Travel - Country 1 - more Check if travelled to country four years ago. show less	N/A
PX161201_Previous_Travel_Country1_LastYear
	PX161201160202	History of Previous Travel - Country 1 - more Check if travelled to country last year. show less	N/A
PX161201_Previous_Travel_Country1_ThisYear
	PX161201160201	History of Previous Travel - Country 1 - more Check if travelled to country this year. show less	N/A
PX161201_Previous_Travel_Country1_ThreeYearsAgo
	PX161201160204	History of Previous Travel - Country 1 - more Check if travelled to country three years ago. show less	N/A
PX161201_Previous_Travel_Country1_TwoYearsAgo
	PX161201160203	History of Previous Travel - Country 1 - more Check if travelled to country two years ago. show less	N/A
PX161201_Previous_Travel_Country2
	PX161201170100	History of Previous Travel - Country 2	N/A
PX161201_Previous_Travel_Country2_30daysFiveYearsAgo
	PX161201170800	History of Previous Travel - Country 2 - more Stay was longer than 30 consecutive days five years ago show less	N/A
PX161201_Previous_Travel_Country2_30daysFourYearsAgo
	PX161201170700	History of Previous Travel - Country 2 - more Stay was longer than 30 consecutive days four years ago show less	N/A
PX161201_Previous_Travel_Country2_30daysLastYear
	PX161201170400	History of Previous Travel - Country 2 - more Stay was longer than 30 consecutive days last year show less	N/A
PX161201_Previous_Travel_Country2_30daysThisYear
	PX161201170300	History of Previous Travel - Country 2 - more Stay was longer than 30 consecutive days this year show less	N/A
PX161201_Previous_Travel_Country2_30daysThreeYearsAgo
	PX161201170600	History of Previous Travel - Country 2 - more Stay was longer than 30 consecutive days three years ago show less	N/A
PX161201_Previous_Travel_Country2_30daysTwoYearsAgo
	PX161201170500	History of Previous Travel - Country 2 - more Stay was longer than 30 consecutive days two years ago show less	N/A
PX161201_Previous_Travel_Country2_FiveYearsAgo
	PX161201170206	History of Previous Travel - Country 2 - more Check if travelled to country five years ago. show less	N/A
PX161201_Previous_Travel_Country2_FourYearsAgo
	PX161201170205	History of Previous Travel - Country 2 - more Check if travelled to country four years ago. show less	N/A
PX161201_Previous_Travel_Country2_LastYear
	PX161201170202	History of Previous Travel - Country 2 - more Check if travelled to country last year. show less	N/A
PX161201_Previous_Travel_Country2_ThisYear
	PX161201170201	History of Previous Travel - Country 2 - more Check if travelled to country this year. show less	N/A
PX161201_Previous_Travel_Country2_ThreeYearsAgo
	PX161201170204	History of Previous Travel - Country 2 - more Check if travelled to country three years ago. show less	N/A
PX161201_Previous_Travel_Country2_TwoYearsAgo
	PX161201170203	History of Previous Travel - Country 2 - more Check if travelled to country two years ago. show less	N/A
PX161201_Previous_Travel_Country3
	PX161201180100	History of Previous Travel - Country 3	N/A
PX161201_Previous_Travel_Country3_30daysFiveYearsAgo
	PX161201180800	History of Previous Travel - Country 3 - more Stay was longer than 30 consecutive days five years ago show less	N/A
PX161201_Previous_Travel_Country3_30daysFourYearsAgo
	PX161201180700	History of Previous Travel - Country 3 - more Stay was longer than 30 consecutive days four years ago show less	N/A
PX161201_Previous_Travel_Country3_30daysLastYear
	PX161201180400	History of Previous Travel - Country 3 - more Stay was longer than 30 consecutive days last year show less	N/A
PX161201_Previous_Travel_Country3_30daysThisYear
	PX161201180300	History of Previous Travel - Country 3 - more Stay was longer than 30 consecutive days this year show less	N/A
PX161201_Previous_Travel_Country3_30daysThreeYearsAgo
	PX161201180600	History of Previous Travel - Country 3 - more Stay was longer than 30 consecutive days three years ago show less	N/A
PX161201_Previous_Travel_Country3_30daysTwoYearsAgo
	PX161201180500	History of Previous Travel - Country 3 - more Stay was longer than 30 consecutive days two years ago show less	N/A
PX161201_Previous_Travel_Country3_FiveYearsAgo
	PX161201180206	History of Previous Travel - Country 3 - more Check if travelled to country five years ago. show less	N/A
PX161201_Previous_Travel_Country3_FourYearsAgo
	PX161201180205	History of Previous Travel - Country 3 - more Check if travelled to country four years ago. show less	N/A
PX161201_Previous_Travel_Country3_LastYear
	PX161201180202	History of Previous Travel - Country 3 - more Check if travelled to country last year. show less	N/A
PX161201_Previous_Travel_Country3_ThisYear
	PX161201180201	History of Previous Travel - Country 3 - more Check if travelled to country this year. show less	N/A
PX161201_Previous_Travel_Country3_ThreeYearsAgo
	PX161201180204	History of Previous Travel - Country 3 - more Check if travelled to country three years ago. show less	N/A
PX161201_Previous_Travel_Country3_TwoYearsAgo
	PX161201180203	History of Previous Travel - Country 3 - more Check if travelled to country two years ago. show less	N/A
PX161201_Previous_Travel_Country4
	PX161201190100	History of Previous Travel - Country 4	N/A
PX161201_Previous_Travel_Country4_30daysFiveYearsAgo
	PX161201190800	History of Previous Travel - Country 4 - more Stay was longer than 30 consecutive days five years ago show less	N/A
PX161201_Previous_Travel_Country4_30daysFourYearsAgo
	PX161201190700	History of Previous Travel - Country 4 - more Stay was longer than 30 consecutive days four years ago show less	N/A
PX161201_Previous_Travel_Country4_30daysLastYear
	PX161201190400	History of Previous Travel - Country 4 - more Stay was longer than 30 consecutive days last year show less	N/A
PX161201_Previous_Travel_Country4_30daysThisYear
	PX161201190300	History of Previous Travel - Country 4 - more Stay was longer than 30 consecutive days this year show less	N/A
PX161201_Previous_Travel_Country4_30daysThreeYearsAgo
	PX161201190600	History of Previous Travel - Country 4 - more Stay was longer than 30 consecutive days three years ago show less	N/A
PX161201_Previous_Travel_Country4_30daysTwoYearsAgo
	PX161201190500	History of Previous Travel - Country 4 - more Stay was longer than 30 consecutive days two years ago show less	N/A
PX161201_Previous_Travel_Country4_FiveYearsAgo
	PX161201190206	History of Previous Travel - Country 4 - more Check if travelled to country five years ago. show less	N/A
PX161201_Previous_Travel_Country4_FourYearsAgo
	PX161201190205	History of Previous Travel - Country 4 - more Check if travelled to country four years ago. show less	N/A
PX161201_Previous_Travel_Country4_LastYear
	PX161201190202	History of Previous Travel - Country 4 - more Check if travelled to country last year. show less	N/A
PX161201_Previous_Travel_Country4_ThisYear
	PX161201190201	History of Previous Travel - Country 4 - more Check if travelled to country this year. show less	N/A
PX161201_Previous_Travel_Country4_ThreeYearsAgo
	PX161201190204	History of Previous Travel - Country 4 - more Check if travelled to country three years ago. show less	N/A
PX161201_Previous_Travel_Country4_TwoYearsAgo
	PX161201190203	History of Previous Travel - Country 4 - more Check if travelled to country two years ago. show less	N/A
PX161201_Previous_Travel_Country5
	PX161201200100	History of Previous Travel - Country 5	N/A
PX161201_Previous_Travel_Country5_30daysFiveYearsAgo
	PX161201200800	History of Previous Travel - Country 5 - more Stay was longer than 30 consecutive days five years ago show less	N/A
PX161201_Previous_Travel_Country5_30daysFourYearsAgo
	PX161201200700	History of Previous Travel - Country 5 - more Stay was longer than 30 consecutive days four years ago show less	N/A
PX161201_Previous_Travel_Country5_30daysLastYear
	PX161201200400	History of Previous Travel - Country 5 - more Stay was longer than 30 consecutive days last year show less	N/A
PX161201_Previous_Travel_Country5_30daysThisYear
	PX161201200300	History of Previous Travel - Country 5 - more Stay was longer than 30 consecutive days this year show less	N/A
PX161201_Previous_Travel_Country5_30daysThreeYearsAgo
	PX161201200600	History of Previous Travel - Country 5 - more Stay was longer than 30 consecutive days three years ago show less	N/A
PX161201_Previous_Travel_Country5_30daysTwoYearsAgo
	PX161201200500	History of Previous Travel - Country 5 - more Stay was longer than 30 consecutive days two years ago show less	N/A
PX161201_Previous_Travel_Country5_FiveYearsAgo
	PX161201200206	History of Previous Travel - Country 5 - more Check if travelled to country five years ago. show less	N/A
PX161201_Previous_Travel_Country5_FourYearsAgo
	PX161201200205	History of Previous Travel - Country 5 - more Check if travelled to country four years ago. show less	N/A
PX161201_Previous_Travel_Country5_LastYear
	PX161201200202	History of Previous Travel - Country 5 - more Check if travelled to country last year. show less	N/A
PX161201_Previous_Travel_Country5_ThisYear
	PX161201200201	History of Previous Travel - Country 5 - more Check if travelled to country this year. show less	N/A
PX161201_Previous_Travel_Country5_ThreeYearsAgo
	PX161201200204	History of Previous Travel - Country 5 - more Check if travelled to country three years ago. show less	N/A
PX161201_Previous_Travel_Country5_TwoYearsAgo
	PX161201200203	History of Previous Travel - Country 5 - more Check if travelled to country two years ago. show less	N/A
PX161201_Previous_Travel_Country6
	PX161201210100	History of Previous Travel - Country 6	N/A
PX161201_Previous_Travel_Country6_30daysFiveYearsAgo
	PX161201210800	History of Previous Travel - Country 6 - more Stay was longer than 30 consecutive days five years ago show less	N/A
PX161201_Previous_Travel_Country6_30daysFourYearsAgo
	PX161201210700	History of Previous Travel - Country 6 - more Stay was longer than 30 consecutive days four years ago show less	N/A
PX161201_Previous_Travel_Country6_30daysLastYear
	PX161201210400	History of Previous Travel - Country 6 - more Stay was longer than 30 consecutive days last year show less	N/A
PX161201_Previous_Travel_Country6_30daysThisYear
	PX161201210300	History of Previous Travel - Country 6 - more Stay was longer than 30 consecutive days this year show less	N/A
PX161201_Previous_Travel_Country6_30daysThreeYearsAgo
	PX161201210600	History of Previous Travel - Country 6 - more Stay was longer than 30 consecutive days three years ago show less	N/A
PX161201_Previous_Travel_Country6_30daysTwoYearsAgo
	PX161201210500	History of Previous Travel - Country 6 - more Stay was longer than 30 consecutive days two years ago show less	N/A
PX161201_Previous_Travel_Country6_FiveYearsAgo
	PX161201210206	History of Previous Travel - Country 6 - more Check if travelled to country five years ago. show less	N/A
PX161201_Previous_Travel_Country6_FourYearsAgo
	PX161201210205	History of Previous Travel - Country 6 - more Check if travelled to country four years ago. show less	N/A
PX161201_Previous_Travel_Country6_LastYear
	PX161201210202	History of Previous Travel - Country 6 - more Check if travelled to country last year. show less	N/A
PX161201_Previous_Travel_Country6_ThisYear
	PX161201210201	History of Previous Travel - Country 6 - more Check if travelled to country this year. show less	N/A
PX161201_Previous_Travel_Country6_ThreeYearsAgo
	PX161201210204	History of Previous Travel - Country 6 - more Check if travelled to country three years ago. show less	N/A
PX161201_Previous_Travel_Country6_TwoYearsAgo
	PX161201210203	History of Previous Travel - Country 6 - more Check if travelled to country two years ago. show less	N/A
PX161201_Primary_Country _Before _10
	PX161201050000	Primary Country of Residency Before Age 10	N/A
PX161201_Reason_For_Travel
	PX161201240000	Reason for Travel Related to Current Illness more (Check One) show less	N/A
PX161201_Recent_Travel_Trip1_Country_1
	PX161201100700	History of Recent Travel - Trip 1 - Country 1	N/A
PX161201_Recent_Travel_Trip1_Country_2
	PX161201100800	History of Recent Travel - Trip 1 - Country 2	N/A
PX161201_Recent_Travel_Trip1_Country_3
	PX161201100900	History of Recent Travel - Trip 1 - Country 3	N/A
PX161201_Recent_Travel_Trip1_Country_4
	PX161201101000	History of Recent Travel - Trip 1 - Country 4	N/A
PX161201_Recent_Travel_Trip1_Country_5
	PX161201100000	History of Recent Travel - Trip 1 - Country 5	N/A
PX161201_Recent_Travel_Trip1_End_Day
	PX161201100500	History of Recent Travel - Trip 1 End Date - Day	N/A
PX161201_Recent_Travel_Trip1_End_Month
	PX161201100400	History of Recent Travel - Trip 1 End Date - Month	N/A
PX161201_Recent_Travel_Trip1_End_Year
	PX161201100600	History of Recent Travel - Trip 1 End Date - Year	N/A
PX161201_Recent_Travel_Trip1_Start_Day
	PX161201100200	History of Recent Travel - Trip 1 Start Date - Day	N/A
PX161201_Recent_Travel_Trip1_Start_Month
	PX161201100100	History of Recent Travel - Trip 1 Start Date more - Month show less	N/A
PX161201_Recent_Travel_Trip1_Start_Year
	PX161201100300	History of Recent Travel - Trip 1 Start Date more - Year show less	N/A
PX161201_Recent_Travel_Trip2_Country_1
	PX161201110700	History of Recent Travel - Trip 2 - Country 1	N/A
PX161201_Recent_Travel_Trip2_Country_2
	PX161201110800	History of Recent Travel - Trip 2 - Country 2	N/A
PX161201_Recent_Travel_Trip2_Country_3
	PX161201110900	History of Recent Travel - Trip 2 - Country 3	N/A
PX161201_Recent_Travel_Trip2_Country_4
	PX161201111000	History of Recent Travel - Trip 2 - Country 4	N/A
PX161201_Recent_Travel_Trip2_Country_5
	PX161201110000	History of Recent Travel - Trip 2 - Country 5	N/A
PX161201_Recent_Travel_Trip2_End_Day
	PX161201110500	History of Recent Travel - Trip 2 End Date - Day	N/A
PX161201_Recent_Travel_Trip2_End_Month
	PX161201110400	History of Recent Travel - Trip 2 End Date - Month	N/A
PX161201_Recent_Travel_Trip2_End_Year
	PX161201110600	History of Recent Travel - Trip 2 End Date - Year	N/A
PX161201_Recent_Travel_Trip2_Start_Day
	PX161201110200	History of Recent Travel - Trip 2 Start Date - Day	N/A
PX161201_Recent_Travel_Trip2_Start_Month
	PX161201110100	History of Recent Travel - Trip 2 Start Date more - Month show less	N/A
PX161201_Recent_Travel_Trip2_Start_Year
	PX161201110300	History of Recent Travel - Trip 2 Start Date more - Year show less	N/A
PX161201_Recent_Travel_Trip3_Country_1
	PX161201120700	History of Recent Travel - Trip 3 - Country 1	N/A
PX161201_Recent_Travel_Trip3_Country_2
	PX161201120800	History of Recent Travel - Trip 3 - Country 2	N/A
PX161201_Recent_Travel_Trip3_Country_3
	PX161201120900	History of Recent Travel - Trip 3 - Country 3	N/A
PX161201_Recent_Travel_Trip3_Country_4
	PX161201121000	History of Recent Travel - Trip 3 - Country 4	N/A
PX161201_Recent_Travel_Trip3_Country_5
	PX161201120000	History of Recent Travel - Trip 3 - Country 5	N/A
PX161201_Recent_Travel_Trip3_End_Day
	PX161201120500	History of Recent Travel - Trip 3 End Date - Day	N/A
PX161201_Recent_Travel_Trip3_End_Month
	PX161201120400	History of Recent Travel - Trip 3 End Date - Month	N/A
PX161201_Recent_Travel_Trip3_End_Year
	PX161201120600	History of Recent Travel - Trip 3 End Date - Year	N/A
PX161201_Recent_Travel_Trip3_Start_Day
	PX161201120200	History of Recent Travel - Trip 3 Start Date - Day	N/A
PX161201_Recent_Travel_Trip3_Start_Month
	PX161201120100	History of Recent Travel - Trip 3 Start Date more - Month show less	N/A
PX161201_Recent_Travel_Trip3_Start_Year
	PX161201120300	History of Recent Travel - Trip 3 Start Date more - Year show less	N/A
PX161201_Recent_Travel_Trip4_Country_1
	PX161201130700	History of Recent Travel - Trip 4 - Country 1	N/A
PX161201_Recent_Travel_Trip4_Country_2
	PX161201130800	History of Recent Travel - Trip 4 - Country 2	N/A
PX161201_Recent_Travel_Trip4_Country_3
	PX161201130900	History of Recent Travel - Trip 4 - Country 3	N/A
PX161201_Recent_Travel_Trip4_Country_4
	PX161201131000	History of Recent Travel - Trip 4 - Country 4	N/A
PX161201_Recent_Travel_Trip4_Country_5
	PX161201130000	History of Recent Travel - Trip 4 - Country 5	N/A
PX161201_Recent_Travel_Trip4_End_Day
	PX161201130500	History of Recent Travel - Trip 4 End Date - Day	N/A
PX161201_Recent_Travel_Trip4_End_Month
	PX161201130400	History of Recent Travel - Trip 4 End Date - Month	N/A
PX161201_Recent_Travel_Trip4_End_Year
	PX161201130600	History of Recent Travel - Trip 4 End Date - Year	N/A
PX161201_Recent_Travel_Trip4_Start_Day
	PX161201130200	History of Recent Travel - Trip 4 Start Date - Day	N/A
PX161201_Recent_Travel_Trip4_Start_Month
	PX161201130100	History of Recent Travel - Trip 4 Start Date more - Month show less	N/A
PX161201_Recent_Travel_Trip4_Start_Year
	PX161201130300	History of Recent Travel - Trip 4 Start Date more - Year show less	N/A
PX161201_Recent_Travel_Trip5_Country_1
	PX161201140700	History of Recent Travel - Trip 5 - Country 1	N/A
PX161201_Recent_Travel_Trip5_Country_2
	PX161201140800	History of Recent Travel - Trip 5 - Country 2	N/A
PX161201_Recent_Travel_Trip5_Country_3
	PX161201140900	History of Recent Travel - Trip 5 - Country 3	N/A
PX161201_Recent_Travel_Trip5_Country_4
	PX161201141000	History of Recent Travel - Trip 5 - Country 4	N/A
PX161201_Recent_Travel_Trip5_Country_5
	PX161201140000	History of Recent Travel - Trip 5 - Country 5	N/A
PX161201_Recent_Travel_Trip5_End_Day
	PX161201140500	History of Recent Travel - Trip 5 End Date - Day	N/A
PX161201_Recent_Travel_Trip5_End_Month
	PX161201140400	History of Recent Travel - Trip 5 End Date - Month	N/A
PX161201_Recent_Travel_Trip5_End_Year
	PX161201140600	History of Recent Travel - Trip 5 End Date - Year	N/A
PX161201_Recent_Travel_Trip5_Start_Day
	PX161201140200	History of Recent Travel - Trip 5 Start Date - Day	N/A
PX161201_Recent_Travel_Trip5_Start_Month
	PX161201140100	History of Recent Travel - Trip 5 Start Date more - Month show less	N/A
PX161201_Recent_Travel_Trip5_Start_Year
	PX161201140300	History of Recent Travel - Trip 5 Start Date more - Year show less	N/A
PX161201_Recent_Travel_Trip6_Country_1
	PX161201150700	History of Recent Travel - Trip 6 - Country 1	N/A
PX161201_Recent_Travel_Trip6_Country_2
	PX161201150800	History of Recent Travel - Trip 6 - Country 2	N/A
PX161201_Recent_Travel_Trip6_Country_3
	PX161201150900	History of Recent Travel - Trip 6 - Country 3	N/A
PX161201_Recent_Travel_Trip6_Country_4
	PX161201151000	History of Recent Travel - Trip 6 - Country 4	N/A
PX161201_Recent_Travel_Trip6_Country_5
	PX161201150000	History of Recent Travel - Trip 6 - Country 5	N/A
PX161201_Recent_Travel_Trip6_End_Day
	PX161201150500	History of Recent Travel - Trip 6 End Date - Day	N/A
PX161201_Recent_Travel_Trip6_End_Month
	PX161201150400	History of Recent Travel - Trip 6 End Date - Month	N/A
PX161201_Recent_Travel_Trip6_End_Year
	PX161201150600	History of Recent Travel - Trip 6 End Date - Year	N/A
PX161201_Recent_Travel_Trip6_Start_Day
	PX161201150200	History of Recent Travel - Trip 6 Start Date - Day	N/A
PX161201_Recent_Travel_Trip6_Start_Month
	PX161201150100	History of Recent Travel - Trip 6 Start Date more - Month show less	N/A
PX161201_Recent_Travel_Trip6_Start_Year
	PX161201150300	History of Recent Travel - Trip 6 Start Date more - Year show less	N/A
PX161201_Risk_Level_Qualifier
	PX161201250000	Risk Level Qualifier (Check One)	N/A
PX161201_Working_Diagnosis_1
	PX161201300100	Working Diagnosis 1	N/A
PX161201_Working_Diagnosis_1_Status
	PX161201300200	Working Diagnosis 1 Status (circle one)	N/A
PX161201_Working_Diagnosis_2
	PX161201310100	Working Diagnosis 2	N/A
PX161201_Working_Diagnosis_2_Status
	PX161201310200	Working Diagnosis 2 Status (circle one)	N/A
PX161201_Working_Diagnosis_3
	PX161201320100	Working Diagnosis 3	N/A
PX161201_Working_Diagnosis_3_Status
	PX161201320200	Working Diagnosis 3 Status (circle one)	N/A
PX161201_Working_Diagnosis_4
	PX161201330100	Working Diagnosis 4	N/A
PX161201_Working_Diagnosis_4_Status
	PX161201330200	Working Diagnosis 4 Status (circle one)	N/A
PX161201_Working_Diagnosis_5
	PX161201340100	Working Diagnosis 5	N/A
PX161201_Working_Diagnosis_5_Status
	PX161201340200	Working Diagnosis 5 Status (circle one)	N/A
PX161201_Working_Diagnosis_6
	PX161201350100	Working Diagnosis 6	N/A
PX161201_Working_Diagnosis_6_Status
	PX161201350200	Working Diagnosis 6 Status(circle one)	N/A

Infectious Diseases and Immunity

Measure Name

International Travel History

Release Date

November 12, 2010

Definition

This measure is a questionnaire to collect data on a respondent's international travel in the past 6 months and the last 5 years and a clinical assessment of the exposure details.

Purpose

This measure can be used to gather information on a respondent's international travel for a clinician to identify the source of potential health exposures.

Keywords

Travel history, Infectious disease, Infectious Diseases and Immunity

Measure Protocols

Protocol ID	Protocol Name
161201	International Travel History

Publications

There are no publications listed for this protocol.

Mapping for PX161201_Age

dbGAP Study	dbGAP Variable	dbGAP Variable Description
A Study of the Genetic Causes of Complex Pediatric Disorders	phv00173610	Age in days at time of testing
Autosomal recessive TPP2 mutations cause a new human immunodeficiency	phv00221155	Subject age
Breast Cancer Study	phv00220930	Age at registration in decades [Years]
CARDIA Cohort	phv00113717	BIRTHDATE (VERIFIED AT EXAM 2)
CARDIA Cohort	phv00114448	DATE LAST STOPPED BCP'S
CARDIA Cohort	phv00115116	BIRTHDATE (VERIFIED AT EXAM 2)
CARDIA Cohort	phv00116381	BIRTHDATE (VERIFIED AT EXAM 2)
CARDIA Cohort	phv00116483	PATIENT DATA: DATE OF BIRTH
CARDIA Cohort	phv00117582	BIRTHDATE (VERIFIED AT EXAM 2)
CARDIA Cohort	phv00119625	BIRTHDATE (VERIFIED AT PPTS LAST EXAM)
CARDIA Cohort	phv00120736	BIRTHDATE (VERIFIED AT PPTS LAST EXAM)
Cardiovascular Health Study (CHS) Cohort	phv00100689	Date of birth in 5 year intervals e.g. 1895 = 1895-1899
Characterization of Human Transcriptome by Computational and HTS Approaches	phv00224899	Subject age
Chromothripsis in Patient WHIM-09	phv00222544	Subject age
Collaborative Study of Genes, Nutrients and Metabolites (CSGNM)	phv00252158	Age
Comparison of custom capture for targeted next generation DNA sequencing	phv00221086	Age of cancer development
DCCT-EDIC Clinical Trial and Follow-up of Persons with Type 1 Diabetes	phv00032010	Date of birth
Diet, Genetic Factors, and the Gut Microbiome in Crohn's Disease	phv00090690	Date of birth
Discovery of Non-ETS Gene Fusions using RNA Sequencing	phv00142649	Age in years
DNA Methylation age and mortality in the Lothian Birth Cohorts	phv00219094	Age at baseline
DNA Methylation age and mortality in the Lothian Birth Cohorts	phv00219095	Age at which death or censoring occurred
Framingham Cohort	phv00177966	Age at Exam 19
Framingham Cohort	phv00177968	Age at Exam 20
Framingham Cohort	phv00177970	Age at Exam 21
Framingham Cohort	phv00177974	Age at Exam 23
Framingham Cohort	phv00177976	Age at Exam 24
Framingham Cohort	phv00177978	Age at Exam 25
Framingham Cohort	phv00177980	Age at Exam 26
Framingham Cohort	phv00177982	Age at Exam 27
Framingham Cohort	phv00177984	Age at Exam 28
Framingham Cohort	phv00182407	Needed for a few FHS EOMI cases where confirmed early onset MI occurred before entering study. The remaining EOMI cases were incident and use of age at baseline and mi_tte_or_censor will provide age at MI for those cases
Framingham Cohort	phv00182410	Age in years at ABI measurement
Framingham Cohort	phv00182412	Age at serum creatinine measurement
Framingham Cohort	phv00182418	Age at DEXA visit
Framingham Cohort	phv00000964	LIFETIME HISTORY OF DIABETES: AGE AT WHICH DIABETES WAS DIAGNOSED, EXAM 7
Framingham Cohort	phv00002984	SMOKING HISTORY: AGE STOPPED SMOKING
Framingham Cohort	phv00002985	SMOKING HISTORY: AGE STARTED
Framingham Cohort	phv00003503	AGE 60, MORE THAN 3 MONTHS-YEAR IN SUNNY CLIMATE
Framingham Cohort	phv00004241	AGE AT HYSTERECTOMY
Framingham Cohort	phv00004648	AGE AT HYSTERECTOMY - FEMALE
Framingham Cohort	phv00005001	AGE AT HYSTERECTOMY (YEARS) - FEMALE
Framingham Cohort	phv00007602	AGE AT WHICH PERIODS STOPPED
Framingham Cohort	phv00007613	AGE STARTED SMOKING CIGARETTES REGULARLY
Framingham Cohort	phv00007614	IF STOPPED, AGE STOPPED
Framingham Cohort	phv00007721	MENOPAUSE: AGE PERIOD STOPPED
Framingham Cohort	phv00007725	MENOPAUSE: AGE PERIODS STARTED
Framingham Cohort	phv00007727	MENOPAUSE: AGE OF TUBAL LIGATION
Framingham Cohort	phv00007734	AGE OF VASECTOMY
Framingham Cohort	phv00007747	AGE START CIGARETTE SMOKING
Framingham Cohort	phv00008423	MENOPAUSE: AGE PERIOD STOPPED
Framingham Cohort	phv00008425	MENOPAUSE: AGE OF HYSTERECTOMY
Framingham Cohort	phv00008428	MENOPAUSE: AGE OF TUBAL LIGATION
Framingham Cohort	phv00008441	AGE AT VASECTOMY
Framingham Cohort	phv00008823	AGE WHEN PERIODS STOPPED (NOTE - AGE WHEN PERIODS STOPPED SHOULD BE TAKEN FROM 1ST EXAM AFTER PERIODS STOPPED.)
Framingham Cohort	phv00008825	AGE AT HYSTERECTOMY
Framingham Cohort	phv00008828	AGE AT TUBAL LIGATION
Framingham Cohort	phv00008844	AGE AT VASECTOMY
Framingham Cohort	phv00009227	AGE WHEN PERIODS STOPPED - FEMALE
Framingham Cohort	phv00009229	AGE AT HYSTERECTOMY - FEMALE
Framingham Cohort	phv00009232	AGE AT TUBAL LIGATION - FEMALE
Framingham Cohort	phv00009249	AGE AT VASECTOMY - MALE
Framingham Cohort	phv00009728	AGE WHEN PERIODS STOPPED (YEARS)
Framingham Cohort	phv00009732	AGE AT HYSTERECTOMY (YEARS)
Framingham Cohort	phv00009735	AGE AT TUBAL LIGATION
Framingham Cohort	phv00009752	AGE AT VASECTOMY (YEARS)
Framingham Cohort	phv00010226	AGE AT HYSTERECTOMY IN INTERIM (YEARS)
Framingham Cohort	phv00010229	AGE AT TUBAL LIGATION
Framingham Cohort	phv00011075	AGE AT WHICH PERIODS HAVE STOPPED FOR ONE YEAR OR MORE
Framingham Cohort	phv00020878	IF YES TO G3A012, AT WHAT AGE DID YOU BEGIN
Framingham Cohort	phv00020880	IF YES TO G3A014, AT WHAT AGE DID YOU BEGIN
Framingham Cohort	phv00020882	IF YES TO G3A016, AT WHAT AGE DID YOU BEGIN
Framingham Cohort	phv00020886	IF YES TO G3A020, AT WHAT AGE DID YOU BEGIN
Framingham Cohort	phv00020900	IF HAD HYSTERECTOMY: AGE OF HYSTERECTOMY?
Framingham Cohort	phv00020902	IF HAD OVARY(S) REMOVED: AGE WHEN OVERIES REMOVED? IF MORE THAN ONE SURGERY, USE AGE AT LAST SURGERY
Framingham Cohort	phv00020906	IF PERIODS STOPPED:AGE WHEN PERIODS STOPPED. IF PERIODS NOW INDUCED BY HORMONES CODE AGE WHEN PERIODS NATURALLY STOPPED
Framingham Cohort	phv00020909	IF TAKEN HRT: WHAT AGE DID YOU BEGIN HORMONE REPLACEMENT THERAPY?
Framingham Cohort	phv00020989	IF EVER CONSUMED ALCOHOL: AT WHAT AGE DID YOU STOP DRINKING ALCOHOL?
Framingham Cohort	phv00021295	ASTHMA: AT WHAT AGE DID IT START? (AGE IN YEARS)
Framingham Cohort	phv00021296	ASTHMA: IF YOU NO LONGER HAVE IT, AT WHAT AGE DID IT STOP? (AGE IN YEARS)
Framingham Cohort	phv00021303	CHRONIC BRONCHITIS: AGE CONDITION BEGAN
Framingham Cohort	phv00021306	EMPHYSEMA: AGE CONDITION BEGAN
Framingham Cohort	phv00021309	COPD: AGE CONDITION BEGAN
Framingham Cohort	phv00021312	SLEEP APNEA: AGE CONDITION BEGAN
Framingham Cohort	phv00021315	PULMONARY FIBROSIS: AGE CONDITION BEGAN
Framingham Cohort	phv00021401	CALCULATED AGE AT EXAM 1
Framingham Cohort	phv00021628	LIVE-BIRTH PREGNANCY #1: YOUR AGE AT THE BIRTH OF THIS CHILD - YEARS
Framingham Cohort	phv00021640	LIVE-BIRTH PREGNANCY #2: YOUR AGE AT THE BIRTH OF THIS CHILD - YEARS
Framingham Cohort	phv00021652	LIVE-BIRTH PREGNANCY #3: YOUR AGE AT THE BIRTH OF THIS CHILD - YEARS
Framingham Cohort	phv00021664	LIVE-BIRTH PREGNANCY #4: YOUR AGE AT THE BIRTH OF THIS CHILD - YEARS
Framingham Cohort	phv00021676	LIVE-BIRTH PREGNANCY #5: YOUR AGE AT THE BIRTH OF THIS CHILD - YEARS
Framingham Cohort	phv00024639	AGE AT KNEE X_RAY FILMS
Framingham Cohort	phv00036419	Age periods stopped
Framingham Cohort	phv00036428	STOP_AGE approximated
Framingham Cohort	phv00054699	AGE AT LAST BIRTHDAY
Framingham Cohort	phv00054701	IF CATARACT QUESTIONABLE OR POSITIVE, AGE FIRST DIAGNOSED (YEARS)
Framingham Cohort	phv00054703	IF MACULAR DEGENERATION (E014) QUESTIONABLE OR POSITIVE, AGE FIRST DIAGNOSED (YEARS)
Framingham Cohort	phv00054705	IF GLAUCOMA (E016) QUESTIONABLE OR POSITIVE, AGE FIRST DIAGNOSED (YEARS)
Framingham Cohort	phv00054942	GLAUCOMA SUSPECT RECALL EXAMINATION: AGE (AT BIRTHDAY PRIOR TO GLAUCOMA SUSPECT RECALL EXAMINATION)
Framingham Cohort	phv00054982	AGE (SAME AS E005), AGE AT LAST BIRTHDAY
Framingham Cohort	phv00055019	AGE AT SCREENING EXAMINATION (3 CLASSES)
Framingham Cohort	phv00055020	AGE AT SCREENING EXAMINAION (5-YEAR INTERVALS)
Framingham Cohort	phv00056587	Age = StdyDtqa - DOB
Framingham Cohort	phv00056723	Age (age = formdate - DOB)
Framingham Cohort	phv00056797	If hi208 or hi208b=yes, how old were you when you first noticed these symptoms (all symptoms checked as present in hi2018a&b)? Age in years (approximate ok)
Framingham Cohort	phv00064594	AGE AT KNEE X_RAY FILMS
Framingham Cohort	phv00064599	AGE AT KNEE X_RAY FILMS
Framingham Cohort	phv00065292	AGE AT X-RAY
Framingham Cohort	phv00070737	Age When Periods Reported Stopped For One Year Or More
Framingham Cohort	phv00072065	HAVE YOU HAD A HYSTERECTOMY (UTERUS/WOMB REMOVED) SINCE YOUR LAST EXAM? - AGE AT HYSTERECTOMY?
Framingham Cohort	phv00072071	IF PERIODS HAVE STOPPED, AGE WHEN PERIODS STOPPED (IF PERIODS NOW INDUCED BY HORMONES, CODE AGE WHEN PERIODS NATURALLY STOPPED)
Framingham Cohort	phv00072074	WHAT AGE DID YOU BEGIN HORMONE REPLACEMENT THERAPY?
Framingham Cohort	phv00072108	AT WHAT AGE DID YOU STOP DRINKING ALCOHOL?
Framingham Cohort	phv00072496	SINCE YOUR LAST EXAM HAVE YOU HAD ...CHRONIC BRONCHITIS: AGE CONDITION BEGAN
Framingham Cohort	phv00072499	SINCE YOUR LAST EXAM HAVE YOU HAD ...EMPHYSEMA: AGE CONDITION BEGAN
Framingham Cohort	phv00072502	SINCE YOUR LAST EXAM HAVE YOU HAD ...COPD: AGE CONDITION BEGAN
Framingham Cohort	phv00072505	SINCE YOUR LAST EXAM HAVE YOU HAD ...SLEEP APNEA: AGE CONDITION BEGAN
Framingham Cohort	phv00072508	SINCE YOUR LAST EXAM HAVE YOU HAD ...PULMONARY FIBROSIS: AGE CONDITION BEGAN
Framingham Cohort	phv00072510	ASTHMA: IF YOU NO LONGER HAVE IT, AT WHAT AGE DID IT STOP?
Framingham Cohort	phv00141916	Age at Death
Framingham Cohort	phv00164567	Age in years at baseline
Framingham Cohort	phv00164590	Incident stroke subtype. Subtype is available only on a subset of samples, so will be missing for some with non-missing age at incident stroke
Framingham Cohort	phv00164594	Age in years at menarche
Framingham Cohort	phv00164602	Age in years at Fibrinogen measurement
Framingham Cohort	phv00164604	Age in years at Factor VII measurement
Framingham Cohort	phv00164608	Age in years at visit of hemostatic factors measurement
Framingham Cohort	phv00164610	Age in years at CRP measurement
Framingham Cohort	phv00164612	Age in years at IL6 measurement
Framingham Cohort	phv00164614	Age in years at ICAM1 measurement
Framingham Cohort	phv00164616	Age in years at P-selectin measurement
Framingham Cohort	phv00164618	Age in years at WBC measurement
Framingham Cohort	phv00164620	Age in years at hemoglobin measurement
Framingham Cohort	phv00164622	Age in years at hematocrit measurement
Framingham Cohort	phv00164626	Age in years at mean corpuscular volume measurement
Framingham Cohort	phv00164628	Age in years at red blood cell count measurement
Framingham Cohort	phv00164638	Age in years at CAC Agatston score measurement
Framingham Cohort	phv00164642	Age in years at IMT measurement
Framingham Cohort	phv00164660	Age in years at EKG measurement
Framingham Cohort	phv00164662	Age in years at serum cystatin c measurement
Framingham Cohort	phv00164664	Age in years at uric acid measurement
Framingham Cohort	phv00164666	Age in years at urinary albumin measurement
Framingham Cohort	phv00164668	Age in years at urinary creatinine measurement
Framingham Cohort	phv00177298	Medical History-Female Reproductive History: Age at hysterectomy?
Framingham Cohort	phv00177300	Medical History-Female Reproductive History: Age when ovaries removed?
Framingham Cohort	phv00177318	Medical History-Alcohol Consumption: At what age did you stop drinking alcohol?
Framingham Cohort	phv00177568	Respiratory Disease Questionnaire-Technician administered: If it started since your last exam, at what age did it start?
Framingham Cohort	phv00177569	Respiratory Disease Questionnaire-Technician administered: If you no longer have it, at what age did it stop?
Framingham Cohort	phv00177930	Age at Exam 1
Framingham Cohort	phv00177932	Age at Exam 2
Framingham Cohort	phv00177934	Age at Exam 3
Framingham Cohort	phv00177936	Age at Exam 4
Framingham Cohort	phv00177938	Age at Exam 5
Framingham Cohort	phv00177940	Age at Exam 6
Framingham Cohort	phv00177942	Age at Exam 7
Framingham Cohort	phv00177944	Age at Exam 8
Framingham Cohort	phv00177946	Age at Exam 9
Framingham Cohort	phv00177948	Age at Exam 10
Framingham Cohort	phv00177950	Age at Exam 11
Framingham Cohort	phv00177952	Age at Exam 12
Framingham Cohort	phv00177954	Age at Exam 13
Framingham Cohort	phv00177956	Age at Exam 14
Framingham Cohort	phv00177958	Age at Exam 15
Framingham Cohort	phv00177960	Age at Exam 16
Framingham Cohort	phv00177962	Age at Exam 17
Framingham Cohort	phv00177964	Age at Exam 18
FusionSeq: Finding Fusions with Paired-End RNA-Seq	phv00156545	Age in years
GenADA/LONG/Imaging (Genetic Alzheimer's Disease Associations)	phv00081346	Age in Years
Genes and Blood Clotting Study (GABC)	phv00124376	At what age did you have your first period?
Genetic Discovery and Application in a Clinical Setting: Continuing a Partnership (eMERGE Phase II)	phv00252028	Age
Genetic Multiple Sclerosis Associations - GeneMSA	phv00072999	Age in years
Genetic Multiple Sclerosis Associations - GeneMSA	phv00073000	Birth date
GENEVA Diabetes Study (NHS/HPFS)	phv00022875	Age categories
GENEVA Study of Preterm Delivery (DNBC/Iowa)	phv00024352	Maternal age at child's birth, from the Medical Birth Register
Genotype-Tissue Expression (GTEx)	phv00169063	Age (Demography)
GWAS of Preterm Birth	phv00161686	Maternal age at delivery
GWAS on Cataract and HDL in the PMRP	phv00181776	How old were you the first time you got a blistering sunburn?
GWAS on Cataract and HDL in the PMRP	phv00181777	About how old were you? (First sunburn)
GWAS on Cataract and HDL in the PMRP	phv00181778	How old were you the last time you got a blistering sunburn?
GWAS on Cataract and HDL in the PMRP	phv00181779	About how old were you? (Last sunburn)
GWAS on Cataract and HDL in the PMRP	phv00181783	How old were you the first time you got a skin rash from sun exposure?
GWAS on Cataract and HDL in the PMRP	phv00181784	About how old were you? (Skin rash)
GWAS on Cataract and HDL in the PMRP	phv00181785	How old were you the last time you got a skin rash from sun exposure?
GWAS on Cataract and HDL in the PMRP	phv00181786	About how old were you? (Last skin rash)
GWAS on Cataract and HDL in the PMRP	phv00181790	How old were you the first time you used a sunlamp?
GWAS on Cataract and HDL in the PMRP	phv00181791	About how old were you? (First sunlamp use)
GWAS on Cataract and HDL in the PMRP	phv00181792	How old were you the last time you used a sunlamp?
GWAS on Cataract and HDL in the PMRP	phv00181793	About how old were you? (Last sunlamp use)
GWAS on Cataract and HDL in the PMRP	phv00181797	How old were you the first time you used a tanning booth?
GWAS on Cataract and HDL in the PMRP	phv00181798	About how old were you? (First tanning booth use)
GWAS on Cataract and HDL in the PMRP	phv00181799	How old were you the last time you used a tanning booth?
GWAS on Cataract and HDL in the PMRP	phv00181800	About how old were you? (Last tanning booth use)
Jackson Heart Study (JHS) Cohort	phv00181208	Age in years at first participant visit
Jackson Heart Study (JHS) Cohort	phv00181229	Age in years at menarche (start of menstruation)
Jackson Heart Study (JHS) Cohort	phv00181231	Age in years of blood fasting insulin measurement in uU/mL
Jackson Heart Study (JHS) Cohort	phv00181233	Age in years of blood fasting glucose measurement in mg/dL
Jackson Heart Study (JHS) Cohort	phv00181235	Age in years at Lp(a) measurement
Jackson Heart Study (JHS) Cohort	phv00181237	Age in years at CRP measurement
Jackson Heart Study (JHS) Cohort	phv00181239	Age in years at WBC measurement
Jackson Heart Study (JHS) Cohort	phv00181241	Age in years at hemoglobin measurement
Jackson Heart Study (JHS) Cohort	phv00181243	Age in years at hematocrit measurement
Jackson Heart Study (JHS) Cohort	phv00181245	Age in years at platelet count measurement
Jackson Heart Study (JHS) Cohort	phv00181247	Age in years at mean corpuscular volume measurement
Jackson Heart Study (JHS) Cohort	phv00181249	Age in years at red blood cell count measurement
Jackson Heart Study (JHS) Cohort	phv00181255	Age in years at secondary blood count measurements (MCV, RBC, Neutrophils, Monocytes, Lymphocytes, Eosinophils, Basophils)
Jackson Heart Study (JHS) Cohort	phv00181257	Age in years at CAC Agatston score measurement
Jackson Heart Study (JHS) Cohort	phv00181260	Age in years at intima media thickness (IMT) measurement
Jackson Heart Study (JHS) Cohort	phv00181268	Age in years at EKG visit
Jackson Heart Study (JHS) Cohort	phv00181271	Age in years at lung function (FEV1 and FVC) measurements
Jackson Heart Study (JHS) Cohort	phv00181291	Age in years at secondary blood count measurements (MCV, RBC, Neutrophils, Monocytes, Lymphocytes, Eosinophils, Basophils)
Jackson Heart Study (JHS) Cohort	phv00181294	Age in years at ABI measurement
Jackson Heart Study (JHS) Cohort	phv00125920	CARe PARTICIPANT DATE OF BIRTH YEAR
Jackson Heart Study (JHS) Cohort	phv00128271	Q13. B. Birth control pills. Age start taking birth control pills? [Visit 1] [Reproductive History Form, RHX]
Jackson Heart Study (JHS) Cohort	phv00128273	Q15. B. Birth control pills. Age stop taking birth control pills? [Visit 1] [Reproductive History Form, RHX]
Jackson Heart Study (JHS) Cohort	phv00165330	Age in years at baseline
Jackson Heart Study (JHS) Cohort	phv00165373	Age in years at CRP measurement
Jackson Heart Study (JHS) Cohort	phv00165381	Age in years at WBC measurement
Jackson Heart Study (JHS) Cohort	phv00165383	Age in years at hemoglobin measurement
Jackson Heart Study (JHS) Cohort	phv00165385	Age in years at hematocrit measurement
Jackson Heart Study (JHS) Cohort	phv00165387	Age in years at platelet count measurement
Jackson Heart Study (JHS) Cohort	phv00165389	Age in years at mean corpuscular volume measurement
Jackson Heart Study (JHS) Cohort	phv00165391	Age in years at red blood cell count measurement
Jackson Heart Study (JHS) Cohort	phv00165401	Age in years at CAC Agatston score measurement
Jackson Heart Study (JHS) Cohort	phv00165405	Age in years at IMT measurement
Jackson Heart Study (JHS) Cohort	phv00165423	Age in years at EKG measurement
Jackson Heart Study (JHS) Cohort	phv00165427	Age in years at uric acid measurement
Jackson Heart Study (JHS) Cohort	phv00165429	Age in years at urinary albumin measurement
Jackson Heart Study (JHS) Cohort	phv00165431	Age in years at urinary creatinine measurement
Melanoma Exome Sequencing	phv00226765	Subject age
Multi-Ethnic Study of Atherosclerosis (MESA) Cohort	phv00083021	AGE AT FIRST LIVE BIRTH
Multi-Ethnic Study of Atherosclerosis (MESA) Cohort	phv00085254	AGE AT FIRST LIVE BIRTH
Multi-Ethnic Study of Atherosclerosis (MESA) Cohort	phv00174654	Q3) HOW OLD ARE YOU? (PPT RESPONSE)
Multi-Ethnic Study of Atherosclerosis (MESA) Cohort	phv00174655	Q3) HOW OLD ARE YOU?
Multi-Ethnic Study of Atherosclerosis (MESA) Cohort	phv00176077	Q3) HOW OLD ARE YOU? (PPT RESPONSE)
Multi-Ethnic Study of Atherosclerosis (MESA) Cohort	phv00176078	Q3) HOW OLD ARE YOU?
NHLBI ARIC Candidate Gene Association Resource (CARe)	phv00190304	Age in years at first participant visit
NHLBI ARIC Candidate Gene Association Resource (CARe)	phv00190336	Age in years at menarche (start of menstruation)
NHLBI ARIC Candidate Gene Association Resource (CARe)	phv00190342	Age in years at Apolipoprotein A1 measurement
NHLBI ARIC Candidate Gene Association Resource (CARe)	phv00190344	Age in years at Apolipoprotein B measurement
NHLBI ARIC Candidate Gene Association Resource (CARe)	phv00190346	Age in years at Fibrinogen measurement
NHLBI ARIC Candidate Gene Association Resource (CARe)	phv00190348	Age in years at Factor VII measurement
NHLBI ARIC Candidate Gene Association Resource (CARe)	phv00190350	Age in years at Factor VIII measurement
NHLBI ARIC Candidate Gene Association Resource (CARe)	phv00190352	Age in years at visit of hemostatic factors measurement
NHLBI ARIC Candidate Gene Association Resource (CARe)	phv00190354	Age in years at CRP measurement
NHLBI ARIC Candidate Gene Association Resource (CARe)	phv00190356	Age in years at IL6 measurement
NHLBI ARIC Candidate Gene Association Resource (CARe)	phv00190358	Age in years at ICAM1 measurement
NHLBI ARIC Candidate Gene Association Resource (CARe)	phv00190360	Age in years at P-selectin measurement
NHLBI ARIC Candidate Gene Association Resource (CARe)	phv00190362	Age in years at WBC measurement
NHLBI ARIC Candidate Gene Association Resource (CARe)	phv00190364	Age in years at hemoglobin measurement
NHLBI ARIC Candidate Gene Association Resource (CARe)	phv00190366	Age in years at hematocrit measurement
NHLBI ARIC Candidate Gene Association Resource (CARe)	phv00190369	Age in years at platelet count measurement
NHLBI ARIC Candidate Gene Association Resource (CARe)	phv00190372	Age in years at red blood cell count measurement
NHLBI ARIC Candidate Gene Association Resource (CARe)	phv00190378	Age in years at secondary blood count measurements (MCV, RBC, Neutrophils, Monocytes, Lymphocytes, Eosinophils, Basophils)
NHLBI ARIC Candidate Gene Association Resource (CARe)	phv00190381	Age in years at intima media thickness (IMT) measurement
NHLBI ARIC Candidate Gene Association Resource (CARe)	phv00190389	Age in years at EKG visit
NHLBI ARIC Candidate Gene Association Resource (CARe)	phv00190392	Age in years at lung function (FEV1 and FVC) measurements
NHLBI GO-ESP Family Studies: Idiopathic Bronchiectasis	phv00171840	Age at which DNA was acquired
NHLBI GO-ESP: Early-Onset Myocardial Infarction (Broad EOMI)	phv00160321	Age in years at baseline LDL
NHLBI GO-ESP: Heart Cohorts Exome Sequencing Project (ARIC)	phv00163946	Age in years at baseline
NHLBI GO-ESP: Heart Cohorts Exome Sequencing Project (ARIC)	phv00163981	Age in years at Fibrinogen measurement
NHLBI GO-ESP: Heart Cohorts Exome Sequencing Project (ARIC)	phv00163983	Age in years at Factor VII measurement
NHLBI GO-ESP: Heart Cohorts Exome Sequencing Project (ARIC)	phv00163985	Age in years at Factor VIII measurement
NHLBI GO-ESP: Heart Cohorts Exome Sequencing Project (ARIC)	phv00163987	Age in years at visit of hemostatic factors measurement
NHLBI GO-ESP: Heart Cohorts Exome Sequencing Project (ARIC)	phv00163989	Age in years at CRP measurement
NHLBI GO-ESP: Heart Cohorts Exome Sequencing Project (ARIC)	phv00163991	Age in years at IL6 measurement
NHLBI GO-ESP: Heart Cohorts Exome Sequencing Project (ARIC)	phv00163993	Age in years at ICAM1 measurement
NHLBI GO-ESP: Heart Cohorts Exome Sequencing Project (ARIC)	phv00163995	Age in years at P-selectin measurement
NHLBI GO-ESP: Heart Cohorts Exome Sequencing Project (ARIC)	phv00163997	Age in years at WBC measurement
NHLBI GO-ESP: Heart Cohorts Exome Sequencing Project (ARIC)	phv00163999	Age in years at hemoglobin measurement
NHLBI GO-ESP: Heart Cohorts Exome Sequencing Project (ARIC)	phv00164001	Age in years at hematocrit measurement
NHLBI GO-ESP: Heart Cohorts Exome Sequencing Project (ARIC)	phv00164003	Age in years at platelet count measurement
NHLBI GO-ESP: Heart Cohorts Exome Sequencing Project (ARIC)	phv00164005	Age in years at mean corpuscular volume measurement
NHLBI GO-ESP: Heart Cohorts Exome Sequencing Project (ARIC)	phv00164007	Age in years at red blood cell count measurement
NHLBI GO-ESP: Heart Cohorts Exome Sequencing Project (ARIC)	phv00164021	Age in years at IMT measurement
NHLBI GO-ESP: Heart Cohorts Exome Sequencing Project (ARIC)	phv00164039	Age in years at EKG measurement
NHLBI GO-ESP: Heart Cohorts Exome Sequencing Project (ARIC)	phv00164043	Age in years at uric acid measurement
NHLBI GO-ESP: Heart Cohorts Exome Sequencing Project (ARIC)	phv00164045	Age in years at urinary albumin measurement
NHLBI GO-ESP: Heart Cohorts Exome Sequencing Project (ARIC)	phv00164047	Age in years at urinary creatinine measurement
NHLBI GO-ESP: Heart Cohorts Exome Sequencing Project (ARIC)	phv00190425	Age in years at secondary blood count measurements (MCV, RBC, Neutrophils, Monocytes, Lymphocytes, Eosinophils, Basophils)
NHLBI GO-ESP: Heart Cohorts Exome Sequencing Project (ARIC)	phv00190428	Age in years at ABI measurement
NHLBI GO-ESP: Heart Cohorts Exome Sequencing Project (CARDIA)	phv00190560	Age in years at baseline
NHLBI GO-ESP: Heart Cohorts Exome Sequencing Project (CARDIA)	phv00190584	Age in years at Fibrinogen measurement
NHLBI GO-ESP: Heart Cohorts Exome Sequencing Project (CARDIA)	phv00190586	Age in years at Factor VII measurement
NHLBI GO-ESP: Heart Cohorts Exome Sequencing Project (CARDIA)	phv00190588	Age in years at Factor VIII measurement
NHLBI GO-ESP: Heart Cohorts Exome Sequencing Project (CARDIA)	phv00190590	Age in years at visit of hemostatic factors measurement
NHLBI GO-ESP: Heart Cohorts Exome Sequencing Project (CARDIA)	phv00190592	Age in years at CRP measurement
NHLBI GO-ESP: Heart Cohorts Exome Sequencing Project (CARDIA)	phv00190594	Age in years at ICAM1 measurement
NHLBI GO-ESP: Heart Cohorts Exome Sequencing Project (CARDIA)	phv00190596	Age in years at P-selectin measurement
NHLBI GO-ESP: Heart Cohorts Exome Sequencing Project (CARDIA)	phv00190598	Age in years at WBC measurement
NHLBI GO-ESP: Heart Cohorts Exome Sequencing Project (CARDIA)	phv00190600	Age in years at hemoglobin measurement
NHLBI GO-ESP: Heart Cohorts Exome Sequencing Project (CARDIA)	phv00190602	Age in years at hematocrit measurement
NHLBI GO-ESP: Heart Cohorts Exome Sequencing Project (CARDIA)	phv00190604	Age in years at platelet count measurement
NHLBI GO-ESP: Heart Cohorts Exome Sequencing Project (CARDIA)	phv00190606	Age in years at red blood cell count measurement
NHLBI GO-ESP: Heart Cohorts Exome Sequencing Project (CARDIA)	phv00190612	Age in years at secondary blood count measurements (MCV, RBC, Neutrophils, Monocytes, Lymphocytes, Eosinophils, Basophils)
NHLBI GO-ESP: Heart Cohorts Exome Sequencing Project (CARDIA)	phv00190614	Age in years at CAC Agatston score measurement
NHLBI GO-ESP: Heart Cohorts Exome Sequencing Project (CARDIA)	phv00190616	Age in years at uric acid measurement
NHLBI GO-ESP: Heart Cohorts Exome Sequencing Project (CARDIA)	phv00190618	Age in years at urinary albumin measurement
NHLBI GO-ESP: Heart Cohorts Exome Sequencing Project (CARDIA)	phv00190620	Age in years at urinary creatinine measurement
NHLBI GO-ESP: Heart Cohorts Exome Sequencing Project (CHS)	phv00181185	Age in years at ABI measurement
NHLBI GO-ESP: Heart Cohorts Exome Sequencing Project (CHS)	phv00165163	Age in years at baseline
NHLBI GO-ESP: Heart Cohorts Exome Sequencing Project (CHS)	phv00165198	Age in years at Fibrinogen measurement
NHLBI GO-ESP: Heart Cohorts Exome Sequencing Project (CHS)	phv00165200	Age in years at Factor VII measurement
NHLBI GO-ESP: Heart Cohorts Exome Sequencing Project (CHS)	phv00165202	Age in years at Factor VIII measurement
NHLBI GO-ESP: Heart Cohorts Exome Sequencing Project (CHS)	phv00165206	Age in years at CRP measurement
NHLBI GO-ESP: Heart Cohorts Exome Sequencing Project (CHS)	phv00165208	Age in years at IL6 measurement
NHLBI GO-ESP: Heart Cohorts Exome Sequencing Project (CHS)	phv00165210	Age in years at ICAM1 measurement
NHLBI GO-ESP: Heart Cohorts Exome Sequencing Project (CHS)	phv00165214	Age in years at WBC measurement
NHLBI GO-ESP: Heart Cohorts Exome Sequencing Project (CHS)	phv00165216	Age in years at hemoglobin measurement
NHLBI GO-ESP: Heart Cohorts Exome Sequencing Project (CHS)	phv00165218	Age in years at hematocrit measurement
NHLBI GO-ESP: Heart Cohorts Exome Sequencing Project (CHS)	phv00165220	Age in years at platelet count measurement
NHLBI GO-ESP: Heart Cohorts Exome Sequencing Project (CHS)	phv00165234	Age in years at CAC Agatston score measurement
NHLBI GO-ESP: Heart Cohorts Exome Sequencing Project (CHS)	phv00165238	Age in years at IMT measurement
NHLBI GO-ESP: Heart Cohorts Exome Sequencing Project (CHS)	phv00165256	Age in years at EKG measurement
NHLBI GO-ESP: Heart Cohorts Exome Sequencing Project (CHS)	phv00165258	Age in years at serum cystatin c measurement
NHLBI GO-ESP: Heart Cohorts Exome Sequencing Project (CHS)	phv00165260	Age in years at uric acid measurement
NHLBI GO-ESP: Heart Cohorts Exome Sequencing Project (CHS)	phv00165262	Age in years at urinary albumin measurement
NHLBI GO-ESP: Heart Cohorts Exome Sequencing Project (CHS)	phv00165264	Age in years at urinary creatinine measurement
NHLBI GO-ESP: Heart Cohorts Exome Sequencing Project (MESA)	phv00178028	Age in years at baseline
NHLBI GO-ESP: Heart Cohorts Exome Sequencing Project (MESA)	phv00178057	AGE IN YEARS AT MENOPAUSE
NHLBI GO-ESP: Heart Cohorts Exome Sequencing Project (MESA)	phv00178064	Age in years at Fibrinogen measurement
NHLBI GO-ESP: Heart Cohorts Exome Sequencing Project (MESA)	phv00178066	Age in years at Factor VIII measurement
NHLBI GO-ESP: Heart Cohorts Exome Sequencing Project (MESA)	phv00178068	Age in years at visit of hemostatic factors measurement
NHLBI GO-ESP: Heart Cohorts Exome Sequencing Project (MESA)	phv00178070	Age in years at CRP measurement
NHLBI GO-ESP: Heart Cohorts Exome Sequencing Project (MESA)	phv00178072	Age in years at ICAM1 measurement
NHLBI GO-ESP: Heart Cohorts Exome Sequencing Project (MESA)	phv00178074	Age in years at CAC Agatston score measurement
NHLBI GO-ESP: Heart Cohorts Exome Sequencing Project (MESA)	phv00178078	Age in years at IMT measurement
NHLBI GO-ESP: Heart Cohorts Exome Sequencing Project (MESA)	phv00178083	Age in years at ABI measurement
NHLBI GO-ESP: Heart Cohorts Exome Sequencing Project (MESA)	phv00178096	Age in years at EKG measurement
NHLBI GO-ESP: Heart Cohorts Exome Sequencing Project (MESA)	phv00178098	Age in years at urinary albumin measurement
NHLBI GO-ESP: Heart Cohorts Exome Sequencing Project (MESA)	phv00178100	Age in years at urinary creatinine measurement
NHLBI GO-ESP: Heart Cohorts Exome Sequencing Project (MESA)	phv00178102	Age in years at serum cystatin c measurement
NICHD Genomic and Proteomic Network for Preterm Birth Research (GPN)	phv00200502	Certain of the date?
NIH Exome Sequencing of Familial Amyotrophic Lateral Sclerosis Project	phv00024106	Subject's age at time of diagnosis in years, or the month and year the subject was born.
NINDS Repository Motor Neuron Disease/ALS Study	phv00000369	The age of the subject in years, or the month and year the subject was born.
Osteosarcoma Genomics	phv00220905	Age of patient at diagnosis
PD-1 Blockade in Non-Small Cell Lung Cancer	phv00253415	Patient's age
Pediatric Cardiac Genetics Consortium (PCGC)	phv00181020	Birth age
Pediatric Cardiac Genetics Consortium (PCGC)	phv00181075	Birth age
SNP Health Association Resource (SHARe) Asthma Resource Project (SHARP)	phv00071049	Age at Baseline. (visit date - date of birth) / 365.25
SNP Health Association Resource (SHARe) Asthma Resource Project (SHARP)	phv00071107	Age at follow-up (visit date - date of birth) / 365.25
SNP Health Association Resource (SHARe) Asthma Resource Project (SHARP)	phv00071157	Age at baseline. (visit date - date of birth) / 365.25
SNP Health Association Resource (SHARe) Asthma Resource Project (SHARP)	phv00071215	Age at follow-up (visit date - date of birth) / 365.25
Study of Melanoma Risk in Australia and the United Kingdom	phv00182332	How old were you when you last used a sunlamp or sunbed
Study of Melanoma Risk in Australia and the United Kingdom	phv00182333	How old were you when you first used a sunlamp or sunbed
The Cardiopulmonary Effects of Particulate Exposure	phv00252410	Age of participant
The Genetic Landscape of Metastasis and Recurrence in HNSCC	phv00253504	Subject age
The Genomic Complexity of Primary Human Prostate Cancer	phv00154530	Age in years
The Human Virome and Febrile Illness in Children	phv00098403	Age in years when participant started study
The Human Virome and Febrile Illness in Children	phv00098404	Age in months when participant started study
The Microbial Ecology of Bacterial Vaginosis	phv00090374	Age in years at study entry
The Sea Islands Genetic Network (SIGNET)	phv00163535	Age in years at enrollment
Type 2 Diabetes Starr County GWAS and Exome Sequencing	phv00066506	Age in years
UIC ACE Exome Sequencing Analysis	phv00200228	Age Equivalent (AE) in months
Whole Genome Profiling to Detect Schizophrenia Methylation Markers	phv00191010	Age (in years)
Women's Health Initiative	phv00078662	Age at First Birth

Mapping for PX161201_Country_Of_Birth

dbGAP Study	dbGAP Variable	dbGAP Variable Description
CIDR: Genome Wide Association Study in Familial Parkinson Disease (PD)	phv00045244	Subject's country of birth (see phs000004: NINDS Repository Neurologically Normal Control Collection)
Columbia University Study of Caribbean Hispanics and Late Onset Alzheimer's disease	phv00180606	Subject's country of birth [Collected in Exam 0, Dominican Republic, Puerto Rico, Other]
Foregut Microbiome in Development of Esophageal Adenocarcinoma	phv00192240	Country of Birth
Framingham Cohort	phv00000481	COUNTRY OF BIRTH
Genome-Wide Association Study of Schizophrenia	phv00020211	Subject's report of country of birth
Genome-Wide Association Study of Schizophrenia	phv00035025	Subjects report of country of birth
HMP Core Microbiome Sampling Protocol A (HMP-A)	phv00158795	Subjects birth country
Ischemic Stroke Genetics Study (ISGS)	phv00024270	Subject's country of birth
Molecular Genetics of Schizophrenia - nonGAIN Sample (MGS_nonGAIN)	phv00071437	Subject's report of country of birth
NIH Exome Sequencing of Familial Amyotrophic Lateral Sclerosis Project	phv00024167	Subject's country of birth
NIH Exome Sequencing of Familial Amyotrophic Lateral Sclerosis Project	phv00024110	Subject's country of birth
NINDS Parkinsonism Study	phv00023924	Subject's country of birth
NINDS Repository Cerebrovascular Disease/Stroke Study	phv00024082	Subject's country of birth
NINDS Repository Motor Neuron Disease/ALS Study	phv00020523	Subject's country of birth
NINDS Repository Neurologically Normal Control Collection	phv00023933	Subject's country of birth
Type 2 Diabetes Starr County GWAS and Exome Sequencing	phv00066508	Country of birth
Whole Genome Association Study of Bipolar Disorder	phv00051872	A4 Country of birth, (African American participants). DIGS4
Whole Genome Association Study of Bipolar Disorder	phv00016949	A4. Country of birth. In which country were you born? (Participants with European ancestry). DIGS4
Whole Genome Association Study of Bipolar Disorder	phv00014674	A 4. Country of Birth, (Participants with European ancestry). DIGS3

Mapping for PX161201_Country_Of_Current_Residence

dbGAP Study	dbGAP Variable	dbGAP Variable Description
Genetics of Cerebral Hemorrhage with Anticoagulation (GOCHA)	phv00169272	Subject's country of residence [Austria, Poland, Spain, Sweden, United States]
High Density SNP Association Analysis of Melanoma	phv00089292	Patient's country of residence including Bolivia, Brazil, Canada, Colombia, Costa Rica, Ecuador, Turkey, United States, Uruguay, Venezuela, other, or unknown
PediGFR - 4C Study Cohort	phv00221114	Country of residence (given by responsible study center)
PediGFR - ESCAPE Trial Cohort	phv00221135	Country of residence (given by responsible study center)
Study of Melanoma Risk in Australia and the United Kingdom	phv00182062	Country of residence

Mapping for PX161201_Gender

dbGAP Study	dbGAP Variable	dbGAP Variable Description
A Genome Wide Scan of Lung Cancer and Smoking	phv00070924	Gender: male or female
A Genome Wide Scan of Lung Cancer and Smoking	phv00022944	Gender: male or female
A Genome Wide Scan of Lung Cancer and Smoking	phv00022954	Gender: male or female
A Genome-Wide Association Study of Peripheral Arterial Disease	phv00076111	Gender of participant
A Multiethnic GWAS of Prostate Cancer	phv00124441	Gender
A Multiethnic GWAS of Prostate Cancer	phv00142466	Gender
A Multiethnic GWAS of Prostate Cancer	phv00142487	Gender
A Novel Recurrent Mutation in MITF Predisposes to Familial and Sporadic Melanoma	phv00164876	Gender of participant
A Study of the Genetic Causes of Complex Pediatric Disorders	phv00173611	Gender of participant as defined by genotype
A Study of the Genetic Causes of Complex Pediatric Disorders	phv00173612	Gender of participant as identified by medical records
A Study of the Genetic Causes of Complex Pediatric Disorders	phv00173613	Gender of participant as identified by survey of patient/patient's parent
A Study of the Genetic Causes of Complex Pediatric Disorders	phv00173631	Gender of participant as identified by medical records
A Study of the Genetic Causes of Complex Pediatric Disorders	phv00173632	Gender of participant as identified by medical records
A Study of the Genetic Causes of Complex Pediatric Disorders	phv00173633	Gender of participant as identified by survey of patient/patient's parent
A Study of the Genetic Causes of Complex Pediatric Disorders	phv00173658	Gender of participant as defined by genotype
A Study of the Genetic Causes of Complex Pediatric Disorders	phv00173659	Gender of participant as identified by medical records
A Study of the Genetic Causes of Complex Pediatric Disorders	phv00173660	Gender of participant as identified by survey of patient/patient's parent
A Study of the Genetic Causes of Complex Pediatric Disorders	phv00173684	Gender of participant as defined by genotype
A Study of the Genetic Causes of Complex Pediatric Disorders	phv00173685	Gender of participant as identified by medical records
A Study of the Genetic Causes of Complex Pediatric Disorders	phv00173686	Gender of participant as identified by survey of patient/patient's parent
A Study of the Genetic Causes of Complex Pediatric Disorders	phv00173712	Gender of participant as identified by genotype
A Study of the Genetic Causes of Complex Pediatric Disorders	phv00173713	Gender of participant as identified by medical records
A Study of the Genetic Causes of Complex Pediatric Disorders	phv00173714	Gender of participant as identified by survey of patient/patient's parent
A Study of the Genetic Causes of Complex Pediatric Disorders	phv00173740	Gender of participant as identified by medical records
A Study of the Genetic Causes of Complex Pediatric Disorders	phv00173741	Gender of participant as identified by survey of patient/patient's parent
Abundant Quantitative Trait Loci Exist for DNA Methylation and Gene Expression in Human Brain	phv00121765	Gender of subject
Acquired Copy Number Alterations in Adult Acute Myeloid Leukemia Genomes	phv00076146	Gender of participant
ADGC Genome Wide Association Study	phv00171927	Gender of participant
African American Breast Cancer GWAS	phv00226032	Gender of participant
Alcohol Dependence GWAS in European- and African Americans	phv00164977	Gender of participant
Alzheimer's Disease Sequencing Project (ADSP)	phv00192277	Sex
Alzheimer's Disease Sequencing Project (ADSP)	phv00192282	Subject's Sex
Alzheimer's Disease Sequencing Project (ADSP)	phv00195357	Sex
Alzheimer's Disease Sequencing Project (ADSP)	phv00218087	Sex
AMD-MMAP Cohort Study: A Joint Genome Wide Association Study	phv00073523	Gender of participant
Antigen Discovery in Melanoma	phv00253333	Sex of subject
ARDSnet and the iSPAAR Consortium: Genetic Studies	phv00196258	Sex
ARRA Autism Sequencing Collaboration	phv00167339	Gender of participant
Asian Indian Diabetic Heart Study (AIDHS)	phv00190530	Gender of participant
Atherosclerosis Risk in Communities (ARIC) Cohort	phv00204449	A. Hospital Information. GENDER Q9 [Cohort Stroke Abstraction Form, STR]
Atherosclerosis Risk in Communities (ARIC) Cohort	phv00204634	Sex (from FTRA22) [Cohort, Exam 2]
Atherosclerosis Risk in Communities (ARIC) Cohort	phv00204711	Sex (uncorrected from FTRA22) [Cohort, Exam 1]
Atherosclerosis Risk in Communities (ARIC) Cohort	phv00204963	Sex (From FTRA22) [Cohort, Exam 4]
Atherosclerosis Risk in Communities (ARIC) Cohort	phv00207078	[Reproductive history]. Sex of participant. Q10 [Health/Medical History, exam 2]
Atherosclerosis Risk in Communities (ARIC) Cohort	phv00208795	Sex (M, F) [Pulmonary Function Test, exam 1]
Atherosclerosis Risk in Communities (ARIC) Cohort	phv00091341	GENDER Q9
Atherosclerosis Risk in Communities (ARIC) Cohort	phv00091486	SEX (from FTRA22)
Atherosclerosis Risk in Communities (ARIC) Cohort	phv00092676	SEX (from FTRA22)
Atherosclerosis Risk in Communities (ARIC) Cohort	phv00092793	SEX (from FTRA22)
Atherosclerosis Risk in Communities (ARIC) Cohort	phv00092928	SEX (from FTRA22)
Atherosclerosis Risk in Communities (ARIC) Cohort	phv00092976	SEX (from FTRA22)
Atherosclerosis Risk in Communities (ARIC) Cohort	phv00094324	GENDER OF PARTICIPANT Q10
Atherosclerosis Risk in Communities (ARIC) Cohort	phv00095960	SEX (from FTRA22)
Atherosclerosis Risk in Communities (ARIC) Cohort	phv00097872	SEX (from FTRA22)
Autism Genome Project (AGP) Consortium - GWAS - Stage I and II	phv00161301	Gender of individual
Autopsy-Confirmed Parkinson Disease GWAS Consortium (APDGC)	phv00167765	Gender of participant
Autosomal recessive PGM3 mutations cause a new Congenital Disorder of Glycosylation	phv00219152	Gender of participant
Autosomal recessive TPP2 mutations cause a new human immunodeficiency	phv00221148	Sex
Autosomal recessive TPP2 mutations cause a new human immunodeficiency	phv00221156	Gender of participant
B and T Cell Determinants of Influenza Vaccine Responses in the Elderly	phv00196119	Gender of participant
Baylor Hopkins Center for Mendelian Genomics (BH CMG)	phv00200346	Subject's gender
Baylor Hopkins Center for Mendelian Genomics (BH CMG)	phv00200351	Subject's gender
Benign Ethnic Neutropenia/Leukopenia (BEN) in African-Americans	phv00173359	Sex of participant
Biology and Molecular Analysis of Human Hematopoiesis Genetics	phv00168002	Gender of participant
Bladder Cancer Clinical Cohorts	phv00202613	Gender of participant
BrainCloud: Data from Human Postmortem Brain Across the Lifespan	phv00163196	Gender of subject
Breakpoint Detection Using Long Insert Whole Genome Sequencing	phv00193968	Gender of participant
Breast Cancer Study	phv00220928	Gender of participant [Female]
Building on GWAS for NHLBI-Diseases : the U.S. CHARGE Consortium (CHARGE-S): ARIC	phv00217489	Gender of participant
Building on GWAS for NHLBI-Diseases : the U.S. CHARGE Consortium (CHARGE-S): ARIC	phv00217501	Gender of participant
Building on GWAS for NHLBI-Diseases : the U.S. CHARGE Consortium (CHARGE-S): ARIC	phv00217516	Gender of participant
Bulgarian Schizophrenia Trio Sequencing Study	phv00197315	Gender of participant
BWH MS Genetic Collection	phv00173776	Gender of the participant
CALGB 80303: Genome-Wide Association Study of Advanced Pancreatic Cancer Patients	phv00159013	Gender. This variable indicates the self reported gender of the patient at the time of registration.
Cancer Genetic Markers of Susceptibility for Bladder Cancer (CGEMS Bladder)	phv00159001	Gender of participant
Cardiovascular Health Study (CHS) Cohort	phv00098797	GENDER
Cardiovascular Health Study (CHS) Cohort	phv00100302	GENDER
Cardiovascular Health Study (CHS) Cohort	phv00100810	GENDER
Cardiovascular Health Study (CHS) Cohort	phv00101950	GENDER
Cardiovascular Health Study (CHS) Cohort	phv00105644	GENDER
Cardiovascular Health Study (CHS) Cohort	phv00106545	GENDER
Cardiovascular Health Study (CHS) Cohort	phv00108393	GENDER
Cardiovascular Health Study (CHS) Cohort	phv00109144	GENDER
Cardiovascular Health Study (CHS) Cohort	phv00109854	GENDER
Cardiovascular Health Study (CHS) Cohort	phv00197398	Gender from a-variables table
Cardiovascular Health Study (CHS) Cohort	phv00197400	Gender
CCDG: Dental Caries and CL/P in Guatemala	phv00164848	Gender of participant.
CCHMC - eMERGE Data	phv00171343	Gender of participant
CD4+ cell transcriptional profiling by RNA sequencing	phv00193953	Gender of participant
Cebu Longitudinal Health and Nutrition Survey (CLHNS)	phv00173303	Gender of participant
CGEMS Breast Cancer GWAS	phv00066640	Gender of participant
CGEMS Prostate Cancer GWAS - Stage 1 - PLCO	phv00082617	Gender of participant
Characterization of a Metastatic Cervical Cancer Using NGS	phv00195732	Gender of participant
Characterization of Human Transcriptome by Computational and HTS Approaches	phv00224900	Gender of participant
Characterization of Pancreatic Adenocarcinoma Patients Using NGS	phv00179509	Gender of participant
Characterization of X Chromosome Inactivation by high-throughput sequencing	phv00219126	Gender of participant
Chinese Alternating Hemiplegia of Childhood (AHC) Disease Study	phv00195755	Gender of participant
Cholesterol and Pharmacogenetics (CAP) Study	phv00167790	Gender [Male or Female]
CHOP Control CNV Study	phv00076212	Gender of participant
Chromothripsis in Patient WHIM-09	phv00222541	Gender of participant
CIDR Whole Exome Sequencing in Joubert Syndrome	phv00161522	Gender of participant
CIDR: Collaborative Study on the Genetics of Alcoholism (COGA)	phv00044647	Participant's gender
CIDR: Genome Wide Association Study in Familial Parkinson Disease (PD)	phv00045171	Gender
CIDR: Genome Wide Association Study in Familial Parkinson Disease (PD)	phv00045239	Gender: male, female (see phs000004: NINDS Repository Neurologically Normal Control Collection)
CIDR: Genome Wide Association Study in Familial Parkinson Disease (PD)	phv00051863	Gender: male, female
CIDR: NGRC Parkinson's Disease Study	phv00075993	Self reported male or female.
Ciliopathies Exome Sequencing Initiative	phv00165082	Gender of subject
CIP: Differential Response to Hydroxyurea and Incidence of Stroke in Sickle Cell Disease	phv00196901	Gender of participant
CIP: Obesity-Diabetes Familial Risk	phv00191155	Gender of participant
Clonal Evolution of Pre-Leukemic HSC Precedes Human AML	phv00173910	Gender of participant
Cohort-Based Genome-Wide Association Study of Glioma (GliomaScan)	phv00195374	Gender of participant [FEMALE, MALE]
Collaborative Association Study of Psoriasis	phv00020011	Sex for cases
Colon Cancer Clinical Cohorts	phv00224966	Gender of participant
Consanguinity and Rare Mutations Outside of MCCC Genes Underlie Non-Specific Phenotypes of MCC Deficiency	phv00202353	Gender of participant
Copy Number Variation in Congenital Kidney Malformations	phv00174498	Gender of participant
CPTAC Proteogenomic Confirmatory Study	phv00225344	Participant gender using the defined categories. [Male; Female; Unknown; Unspecified]
CPTAC Proteogenomic Confirmatory Study	phv00225292	Participant gender using the defined categories. [Male; Female; Unknown; Unspecified]
CSER-MedSeq	phv00252786	Gender of subject
CTLA4 haploinsufficiency and immune dysregulation	phv00217692	Gender
CTLA4 haploinsufficiency and immune dysregulation	phv00217701	Subject's gender
Cutaneous Microbiome in Psoriasis (HMP Demonstration Study)	phv00090655	Gender of subject
DCCT-EDIC Clinical Trial and Follow-up of Persons with Type 1 Diabetes	phv00024957	Patient's gender
DCCT-EDIC Clinical Trial and Follow-up of Persons with Type 1 Diabetes	phv00025695	Patient's gender
DCCT-EDIC Clinical Trial and Follow-up of Persons with Type 1 Diabetes	phv00026039	Patient's gender
DCCT-EDIC Clinical Trial and Follow-up of Persons with Type 1 Diabetes	phv00027102	Subject's gender
DCCT-EDIC Clinical Trial and Follow-up of Persons with Type 1 Diabetes	phv00027796	Patient's gender (coded m or f)
DCCT-EDIC Clinical Trial and Follow-up of Persons with Type 1 Diabetes	phv00028718	Patient's gender (form 001)
DCCT-EDIC Clinical Trial and Follow-up of Persons with Type 1 Diabetes	phv00028966	Patient's gender
DCCT-EDIC Clinical Trial and Follow-up of Persons with Type 1 Diabetes	phv00029309	Patient's gender (from form 001)
DCCT-EDIC Clinical Trial and Follow-up of Persons with Type 1 Diabetes	phv00030102	Patient's gender (0=male,1=female)
DCCT-EDIC Clinical Trial and Follow-up of Persons with Type 1 Diabetes	phv00030340	Patient's gender
DCCT-EDIC Clinical Trial and Follow-up of Persons with Type 1 Diabetes	phv00030687	Patient's gender
DCCT-EDIC Clinical Trial and Follow-up of Persons with Type 1 Diabetes	phv00030750	Patient's gender (form 001)
DCCT-EDIC Clinical Trial and Follow-up of Persons with Type 1 Diabetes	phv00030936	Patient's gender (from form 001)
DCCT-EDIC Clinical Trial and Follow-up of Persons with Type 1 Diabetes	phv00031783	Indicator: male gender
DCCT-EDIC Clinical Trial and Follow-up of Persons with Type 1 Diabetes	phv00034144	Patient's gender
DCCT-EDIC Clinical Trial and Follow-up of Persons with Type 1 Diabetes	phv00034546	Gender
DCCT-EDIC Clinical Trial and Follow-up of Persons with Type 1 Diabetes	phv00051664	A4. Identifying information. Gender
DCEG Lung Cancer Study	phv00159402	Gender of participant [FEMALE, MALE]
DFCI Brown Lab CLL Sequencing Study	phv00253297	Gender of participant
DFCI Colorectal Cancer Cohorts	phv00201985	Gender of participant
Diabetes Prevention Program Genetics (DPPG)	phv00201854	Gender of participant
Diet, Genetic Factors, and the Gut Microbiome in Crohn's Disease	phv00090824	Gender
Discovery of Non-ETS Gene Fusions using RNA Sequencing	phv00142652	Gender of participant
DNA Methylation Analysis of Prostate Cancer	phv00181136	Gender of subject
Dobyns DBD	phv00167279	Gender of participant
Drug Resistant Hypertension in African Americans' Exome	phv00164734	Gender of participant
Effect of Crohn's Disease Risk Alleles on Enteric Microbiota	phv00090595	Gender of participant
eMERGE Genome-Wide Association Studies of Obesity	phv00163596	Gender of subject.
eMERGE Genome-Wide Association Studies of Obesity (Metabochip)	phv00163767	Gender of subject.
eMERGE Network Combined Dataset	phv00182445	Gender of participant
eMERGE Network Study of Resistant Hypertension	phv00163159	Gender of participant.
Epi4K: Gene Discovery in 4,000 Epilepsy Genomes	phv00195566	Gender
Epi4K: Gene Discovery in 4,000 Epilepsy Genomes: Genetic Analyses in Epileptic Encephalopathies	phv00195518	Gender
Epi4K: Gene Discovery in 4,000 Epilepsy Genomes: Genetic Analyses in Epileptic Encephalopathies	phv00195521	Self-declared gender of participant
Epi4K: Gene Discovery in 4,000 Epilepsy Genomes: Genetic Analyses in Epileptic Encephalopathies	phv00201601	Self-declared gender of participant
Epigenetic and Genetic Profiling in Lymphoma	phv00226818	Gender of participant
Epigenetic Marks as Peripheral Biomarkers of Autism	phv00191073	Gender of participant
Epigenetic Marks as Peripheral Biomarkers of Autism	phv00191076	Subject's gender
Epigenetic Profiling of Human Colorectal Cancer	phv00161708	Gender of participant
Exome Chip Study of NIMH Controls	phv00192229	Gender of participant
Exome Sequencing in Schizophrenia Families	phv00201670	Gender of participant
Exome sequencing of a family with thrombocytopenia and leukemia	phv00224938	Gender of participant
Exome Sequencing of arPEO	phv00162961	Gender of Participant
Exome Sequencing of Esophageal Adenocarcinoma	phv00190857	Participant gender as Male or Female
Exome Sequencing of Pleuropulmonary Blastoma	phv00173412	Participant's gender as Male or Female
Familial Exome Sequencing in Rare Pediatric Phenotypes	phv00179539	Gender of participant
Family Genomics of Congenital Heart Defects	phv00202713	Subject's gender
Foregut Microbiome in Development of Esophageal Adenocarcinoma	phv00090620	Gender of subject
Framingham Cohort	phv00164565	Values: Male; Female
Framingham Cohort	phv00177929	Participant gender
Framingham Cohort	phv00021228	SEX OF PARTICIPANT
Framingham Cohort	phv00024071	Gender
Framingham SHARe Social Network	phv00073864	Gender
FusionSeq: Finding Fusions with Paired-End RNA-Seq	phv00156548	Gender of participant
GAW16 Framingham and Simulated Data	phv00063695	Gender 1: Male, 2: Female
GAW16 Framingham and Simulated Data	phv00063727	Gender 1: Male, 2: Female
GAW16 Framingham and Simulated Data	phv00063759	Gender 1: Male, 2: Female
GAW16 Framingham and Simulated Data	phv00063791	Gender 1: Male, 2: Female
GAW16 Framingham and Simulated Data	phv00063823	Gender 1: Male, 2: Female
GAW16 Framingham and Simulated Data	phv00063855	Gender 1: Male, 2: Female
GAW16 Framingham and Simulated Data	phv00063887	Gender 1: Male, 2: Female
GAW16 Framingham and Simulated Data	phv00063919	Gender 1: Male, 2: Female
GAW16 Framingham and Simulated Data	phv00063951	Gender 1: Male, 2: Female
GAW16 Framingham and Simulated Data	phv00063983	Gender 1: Male, 2: Female
GAW16 Framingham and Simulated Data	phv00064015	Gender 1: Male, 2: Female
GAW16 Framingham and Simulated Data	phv00064047	Gender 1: Male, 2: Female
GAW16 Framingham and Simulated Data	phv00064079	Gender 1: Male, 2: Female
GAW16 Framingham and Simulated Data	phv00064111	Gender 1: Male, 2: Female
GAW16 Framingham and Simulated Data	phv00064143	Gender 1: Male, 2: Female
GAW16 Framingham and Simulated Data	phv00064175	Gender 1: Male, 2: Female
GAW16 Framingham and Simulated Data	phv00064207	Gender 1: Male, 2: Female
GAW16 Framingham and Simulated Data	phv00064239	Gender 1: Male, 2: Female
GAW16 Framingham and Simulated Data	phv00064271	Gender 1: Male, 2: Female
GAW16 Framingham and Simulated Data	phv00064303	Gender 1: Male, 2: Female
GAW16 Framingham and Simulated Data	phv00064335	Gender 1: Male, 2: Female
GAW16 Framingham and Simulated Data	phv00064367	Gender 1: Male, 2: Female
GAW16 Framingham and Simulated Data	phv00064399	Gender 1: Male, 2: Female
GAW16 Framingham and Simulated Data	phv00064431	Gender 1: Male, 2: Female
GAW16 Framingham and Simulated Data	phv00064463	Gender 1: Male, 2: Female
GAW16 Framingham and Simulated Data	phv00064495	Gender 1: Male, 2: Female
GAW16 Framingham and Simulated Data	phv00064527	Gender 1: Male, 2: Female
GAW16 Framingham and Simulated Data	phv00064559	GENDER:1=MALE,2=FEMALE
GAW16 Framingham and Simulated Data	phv00064567	Gender
GAW16 Framingham and Simulated Data	phv00073845	Gender
GAW16 Framingham and Simulated Data	phv00051702	GENDER:1=MALE,2=FEMALE
GAW16 Framingham and Simulated Data	phv00051770	GENDER:1=MALE,2=FEMALE
GAW16 Framingham and Simulated Data	phv00051839	GENDER:1=MALE,2=FEMALE
GAW16 Framingham and Simulated Data	phv00058159	Gender 1: Male, 2: Female
GAW16 Framingham and Simulated Data	phv00058191	Gender 1: Male, 2: Female
GAW16 Framingham and Simulated Data	phv00058223	Gender 1: Male, 2: Female
GAW16 Framingham and Simulated Data	phv00058255	Gender 1: Male, 2: Female
GAW16 Framingham and Simulated Data	phv00058287	Gender 1: Male, 2: Female
GAW16 Framingham and Simulated Data	phv00058319	Gender 1: Male, 2: Female
GAW16 Framingham and Simulated Data	phv00058351	Gender 1: Male, 2: Female
GAW16 Framingham and Simulated Data	phv00058383	Gender 1: Male, 2: Female
GAW16 Framingham and Simulated Data	phv00058415	Gender 1: Male, 2: Female
GAW16 Framingham and Simulated Data	phv00058447	Gender 1: Male, 2: Female
GAW16 Framingham and Simulated Data	phv00058479	Gender 1: Male, 2: Female
GAW16 Framingham and Simulated Data	phv00058511	Gender 1: Male, 2: Female
GAW16 Framingham and Simulated Data	phv00058543	Gender 1: Male, 2: Female
GAW16 Framingham and Simulated Data	phv00058575	Gender 1: Male, 2: Female
GAW16 Framingham and Simulated Data	phv00058607	Gender 1: Male, 2: Female
GAW16 Framingham and Simulated Data	phv00058639	Gender 1: Male, 2: Female
GAW16 Framingham and Simulated Data	phv00058671	Gender 1: Male, 2: Female
GAW16 Framingham and Simulated Data	phv00058703	Gender 1: Male, 2: Female
GAW16 Framingham and Simulated Data	phv00058735	Gender 1: Male, 2: Female
GAW16 Framingham and Simulated Data	phv00058767	Gender 1: Male, 2: Female
GAW16 Framingham and Simulated Data	phv00058799	Gender 1: Male, 2: Female
GAW16 Framingham and Simulated Data	phv00058831	Gender 1: Male, 2: Female
GAW16 Framingham and Simulated Data	phv00058863	Gender 1: Male, 2: Female
GAW16 Framingham and Simulated Data	phv00058895	Gender 1: Male, 2: Female
GAW16 Framingham and Simulated Data	phv00058927	Gender 1: Male, 2: Female
GAW16 Framingham and Simulated Data	phv00058959	Gender 1: Male, 2: Female
GAW16 Framingham and Simulated Data	phv00058991	Gender 1: Male, 2: Female
GAW16 Framingham and Simulated Data	phv00059023	Gender 1: Male, 2: Female
GAW16 Framingham and Simulated Data	phv00059055	Gender 1: Male, 2: Female
GAW16 Framingham and Simulated Data	phv00059087	Gender 1: Male, 2: Female
GAW16 Framingham and Simulated Data	phv00059119	Gender 1: Male, 2: Female
GAW16 Framingham and Simulated Data	phv00059151	Gender 1: Male, 2: Female
GAW16 Framingham and Simulated Data	phv00059183	Gender 1: Male, 2: Female
GAW16 Framingham and Simulated Data	phv00059215	Gender 1: Male, 2: Female
GAW16 Framingham and Simulated Data	phv00059247	Gender 1: Male, 2: Female
GAW16 Framingham and Simulated Data	phv00059279	Gender 1: Male, 2: Female
GAW16 Framingham and Simulated Data	phv00059311	Gender 1: Male, 2: Female
GAW16 Framingham and Simulated Data	phv00059343	Gender 1: Male, 2: Female
GAW16 Framingham and Simulated Data	phv00059375	Gender 1: Male, 2: Female
GAW16 Framingham and Simulated Data	phv00059407	Gender 1: Male, 2: Female
GAW16 Framingham and Simulated Data	phv00059439	Gender 1: Male, 2: Female
GAW16 Framingham and Simulated Data	phv00059471	Gender 1: Male, 2: Female
GAW16 Framingham and Simulated Data	phv00059503	Gender 1: Male, 2: Female
GAW16 Framingham and Simulated Data	phv00059535	Gender 1: Male, 2: Female
GAW16 Framingham and Simulated Data	phv00059567	Gender 1: Male, 2: Female
GAW16 Framingham and Simulated Data	phv00059599	Gender 1: Male, 2: Female
GAW16 Framingham and Simulated Data	phv00059631	Gender 1: Male, 2: Female
GAW16 Framingham and Simulated Data	phv00059663	Gender 1: Male, 2: Female
GAW16 Framingham and Simulated Data	phv00059695	Gender 1: Male, 2: Female
GAW16 Framingham and Simulated Data	phv00059727	Gender 1: Male, 2: Female
GAW16 Framingham and Simulated Data	phv00059759	Gender 1: Male, 2: Female
GAW16 Framingham and Simulated Data	phv00059791	Gender 1: Male, 2: Female
GAW16 Framingham and Simulated Data	phv00059823	Gender 1: Male, 2: Female
GAW16 Framingham and Simulated Data	phv00059855	Gender 1: Male, 2: Female
GAW16 Framingham and Simulated Data	phv00059887	Gender 1: Male, 2: Female
GAW16 Framingham and Simulated Data	phv00059919	Gender 1: Male, 2: Female
GAW16 Framingham and Simulated Data	phv00059951	Gender 1: Male, 2: Female
GAW16 Framingham and Simulated Data	phv00059983	Gender 1: Male, 2: Female
GAW16 Framingham and Simulated Data	phv00060015	Gender 1: Male, 2: Female
GAW16 Framingham and Simulated Data	phv00060047	Gender 1: Male, 2: Female
GAW16 Framingham and Simulated Data	phv00060079	Gender 1: Male, 2: Female
GAW16 Framingham and Simulated Data	phv00060111	Gender 1: Male, 2: Female
GAW16 Framingham and Simulated Data	phv00060143	Gender 1: Male, 2: Female
GAW16 Framingham and Simulated Data	phv00060175	Gender 1: Male, 2: Female
GAW16 Framingham and Simulated Data	phv00060207	Gender 1: Male, 2: Female
GAW16 Framingham and Simulated Data	phv00060239	Gender 1: Male, 2: Female
GAW16 Framingham and Simulated Data	phv00060271	Gender 1: Male, 2: Female
GAW16 Framingham and Simulated Data	phv00060303	Gender 1: Male, 2: Female
GAW16 Framingham and Simulated Data	phv00060335	Gender 1: Male, 2: Female
GAW16 Framingham and Simulated Data	phv00060367	Gender 1: Male, 2: Female
GAW16 Framingham and Simulated Data	phv00060399	Gender 1: Male, 2: Female
GAW16 Framingham and Simulated Data	phv00060431	Gender 1: Male, 2: Female
GAW16 Framingham and Simulated Data	phv00060463	Gender 1: Male, 2: Female
GAW16 Framingham and Simulated Data	phv00060495	Gender 1: Male, 2: Female
GAW16 Framingham and Simulated Data	phv00060527	Gender 1: Male, 2: Female
GAW16 Framingham and Simulated Data	phv00060559	Gender 1: Male, 2: Female
GAW16 Framingham and Simulated Data	phv00060591	Gender 1: Male, 2: Female
GAW16 Framingham and Simulated Data	phv00060623	Gender 1: Male, 2: Female
GAW16 Framingham and Simulated Data	phv00060655	Gender 1: Male, 2: Female
GAW16 Framingham and Simulated Data	phv00060687	Gender 1: Male, 2: Female
GAW16 Framingham and Simulated Data	phv00060719	Gender 1: Male, 2: Female
GAW16 Framingham and Simulated Data	phv00060751	Gender 1: Male, 2: Female
GAW16 Framingham and Simulated Data	phv00060783	Gender 1: Male, 2: Female
GAW16 Framingham and Simulated Data	phv00060815	Gender 1: Male, 2: Female
GAW16 Framingham and Simulated Data	phv00060847	Gender 1: Male, 2: Female
GAW16 Framingham and Simulated Data	phv00060879	Gender 1: Male, 2: Female
GAW16 Framingham and Simulated Data	phv00060911	Gender 1: Male, 2: Female
GAW16 Framingham and Simulated Data	phv00060943	Gender 1: Male, 2: Female
GAW16 Framingham and Simulated Data	phv00060975	Gender 1: Male, 2: Female
GAW16 Framingham and Simulated Data	phv00061007	Gender 1: Male, 2: Female
GAW16 Framingham and Simulated Data	phv00061039	Gender 1: Male, 2: Female
GAW16 Framingham and Simulated Data	phv00061071	Gender 1: Male, 2: Female
GAW16 Framingham and Simulated Data	phv00061103	Gender 1: Male, 2: Female
GAW16 Framingham and Simulated Data	phv00061135	Gender 1: Male, 2: Female
GAW16 Framingham and Simulated Data	phv00061167	Gender 1: Male, 2: Female
GAW16 Framingham and Simulated Data	phv00061199	Gender 1: Male, 2: Female
GAW16 Framingham and Simulated Data	phv00061231	Gender 1: Male, 2: Female
GAW16 Framingham and Simulated Data	phv00061263	Gender 1: Male, 2: Female
GAW16 Framingham and Simulated Data	phv00061295	Gender 1: Male, 2: Female
GAW16 Framingham and Simulated Data	phv00061327	Gender 1: Male, 2: Female
GAW16 Framingham and Simulated Data	phv00061359	Gender 1: Male, 2: Female
GAW16 Framingham and Simulated Data	phv00061391	Gender 1: Male, 2: Female
GAW16 Framingham and Simulated Data	phv00061423	Gender 1: Male, 2: Female
GAW16 Framingham and Simulated Data	phv00061455	Gender 1: Male, 2: Female
GAW16 Framingham and Simulated Data	phv00061487	Gender 1: Male, 2: Female
GAW16 Framingham and Simulated Data	phv00061519	Gender 1: Male, 2: Female
GAW16 Framingham and Simulated Data	phv00061551	Gender 1: Male, 2: Female
GAW16 Framingham and Simulated Data	phv00061583	Gender 1: Male, 2: Female
GAW16 Framingham and Simulated Data	phv00061615	Gender 1: Male, 2: Female
GAW16 Framingham and Simulated Data	phv00061647	Gender 1: Male, 2: Female
GAW16 Framingham and Simulated Data	phv00061679	Gender 1: Male, 2: Female
GAW16 Framingham and Simulated Data	phv00061711	Gender 1: Male, 2: Female
GAW16 Framingham and Simulated Data	phv00061743	Gender 1: Male, 2: Female
GAW16 Framingham and Simulated Data	phv00061775	Gender 1: Male, 2: Female
GAW16 Framingham and Simulated Data	phv00061807	Gender 1: Male, 2: Female
GAW16 Framingham and Simulated Data	phv00061839	Gender 1: Male, 2: Female
GAW16 Framingham and Simulated Data	phv00061871	Gender 1: Male, 2: Female
GAW16 Framingham and Simulated Data	phv00061903	Gender 1: Male, 2: Female
GAW16 Framingham and Simulated Data	phv00061935	Gender 1: Male, 2: Female
GAW16 Framingham and Simulated Data	phv00061967	Gender 1: Male, 2: Female
GAW16 Framingham and Simulated Data	phv00061999	Gender 1: Male, 2: Female
GAW16 Framingham and Simulated Data	phv00062031	Gender 1: Male, 2: Female
GAW16 Framingham and Simulated Data	phv00062063	Gender 1: Male, 2: Female
GAW16 Framingham and Simulated Data	phv00062095	Gender 1: Male, 2: Female
GAW16 Framingham and Simulated Data	phv00062127	Gender 1: Male, 2: Female
GAW16 Framingham and Simulated Data	phv00062159	Gender 1: Male, 2: Female
GAW16 Framingham and Simulated Data	phv00062191	Gender 1: Male, 2: Female
GAW16 Framingham and Simulated Data	phv00062223	Gender 1: Male, 2: Female
GAW16 Framingham and Simulated Data	phv00062255	Gender 1: Male, 2: Female
GAW16 Framingham and Simulated Data	phv00062287	Gender 1: Male, 2: Female
GAW16 Framingham and Simulated Data	phv00062319	Gender 1: Male, 2: Female
GAW16 Framingham and Simulated Data	phv00062351	Gender 1: Male, 2: Female
GAW16 Framingham and Simulated Data	phv00062383	Gender 1: Male, 2: Female
GAW16 Framingham and Simulated Data	phv00062415	Gender 1: Male, 2: Female
GAW16 Framingham and Simulated Data	phv00062447	Gender 1: Male, 2: Female
GAW16 Framingham and Simulated Data	phv00062479	Gender 1: Male, 2: Female
GAW16 Framingham and Simulated Data	phv00062511	Gender 1: Male, 2: Female
GAW16 Framingham and Simulated Data	phv00062543	Gender 1: Male, 2: Female
GAW16 Framingham and Simulated Data	phv00062575	Gender 1: Male, 2: Female
GAW16 Framingham and Simulated Data	phv00062607	Gender 1: Male, 2: Female
GAW16 Framingham and Simulated Data	phv00062639	Gender 1: Male, 2: Female
GAW16 Framingham and Simulated Data	phv00062671	Gender 1: Male, 2: Female
GAW16 Framingham and Simulated Data	phv00062703	Gender 1: Male, 2: Female
GAW16 Framingham and Simulated Data	phv00062735	Gender 1: Male, 2: Female
GAW16 Framingham and Simulated Data	phv00062767	Gender 1: Male, 2: Female
GAW16 Framingham and Simulated Data	phv00062799	Gender 1: Male, 2: Female
GAW16 Framingham and Simulated Data	phv00062831	Gender 1: Male, 2: Female
GAW16 Framingham and Simulated Data	phv00062863	Gender 1: Male, 2: Female
GAW16 Framingham and Simulated Data	phv00062895	Gender 1: Male, 2: Female
GAW16 Framingham and Simulated Data	phv00062927	Gender 1: Male, 2: Female
GAW16 Framingham and Simulated Data	phv00062959	Gender 1: Male, 2: Female
GAW16 Framingham and Simulated Data	phv00062991	Gender 1: Male, 2: Female
GAW16 Framingham and Simulated Data	phv00063023	Gender 1: Male, 2: Female
GAW16 Framingham and Simulated Data	phv00063055	Gender 1: Male, 2: Female
GAW16 Framingham and Simulated Data	phv00063087	Gender 1: Male, 2: Female
GAW16 Framingham and Simulated Data	phv00063119	Gender 1: Male, 2: Female
GAW16 Framingham and Simulated Data	phv00063151	Gender 1: Male, 2: Female
GAW16 Framingham and Simulated Data	phv00063183	Gender 1: Male, 2: Female
GAW16 Framingham and Simulated Data	phv00063215	Gender 1: Male, 2: Female
GAW16 Framingham and Simulated Data	phv00063247	Gender 1: Male, 2: Female
GAW16 Framingham and Simulated Data	phv00063279	Gender 1: Male, 2: Female
GAW16 Framingham and Simulated Data	phv00063311	Gender 1: Male, 2: Female
GAW16 Framingham and Simulated Data	phv00063343	Gender 1: Male, 2: Female
GAW16 Framingham and Simulated Data	phv00063375	Gender 1: Male, 2: Female
GAW16 Framingham and Simulated Data	phv00063407	Gender 1: Male, 2: Female
GAW16 Framingham and Simulated Data	phv00063439	Gender 1: Male, 2: Female
GAW16 Framingham and Simulated Data	phv00063471	Gender 1: Male, 2: Female
GAW16 Framingham and Simulated Data	phv00063503	Gender 1: Male, 2: Female
GAW16 Framingham and Simulated Data	phv00063535	Gender 1: Male, 2: Female
GAW16 Framingham and Simulated Data	phv00063567	Gender 1: Male, 2: Female
GAW16 Framingham and Simulated Data	phv00063599	Gender 1: Male, 2: Female
GAW16 Framingham and Simulated Data	phv00063631	Gender 1: Male, 2: Female
GAW16 Framingham and Simulated Data	phv00063663	Gender 1: Male, 2: Female
GDNF and Anxiety	phv00217716	Gender of participant
GEI Studies - Psoriasis	phv00202295	Gender of participant
Geisinger eMERGE - Abdominal Aortic Aneurysm Project (AAAP)	phv00163633	Gender of subject.
Geisinger eMERGE - MyCode Project	phv00163391	Gender of subject.
GenADA/LONG/Imaging (Genetic Alzheimer's Disease Associations)	phv00081063	Reported gender of participant
Gene Mutation and Rescue in Congenital Diaphragmatic Hernia	phv00167961	Gender of participant
Genentech Lung Cancer Sequencing	phv00112391	Gender of participant
Genentech Whole Genome Sequencing of Four Hepatocellular Carcinoma Patients	phv00163921	Gender of participant
Genes and Blood Clotting Study (GABC)	phv00124352	Participant gender
Genetic Analysis of Hirschsprung Disease	phv00168116	Gender of participant
Genetic Associations in Idiopathic Talipes Equinovarus (GAIT)	phv00141836	Gender of participant
Genetic Basis of Pulmonary Non-tuberculous Mycobacterial Infections	phv00200422	Gender of participant
Genetic Basis of XMEN Disease	phv00160299	Gender of participant
Genetic Defects in Familial Renal Disorders	phv00167981	Gender of participant
Genetic Epidemiology Network of Salt Sensitivity (GenSalt)	phv00217799	Sex
Genetic Epidemiology Network of Salt Sensitivity (GenSalt)	phv00217805	Sex
Genetic Epidemiology of COPD (COPDGene)	phv00159571	Gender
Genetic Heterogeneity of Diffuse Large B Cell Lymphoma	phv00181331	Gender
Genetic Measurement of Memory B-cell Recall Using Antibody Repertoire Sequencing	phv00195584	Gender of participant
Genetic Modifiers of Huntington's Disease	phv00173894	Gender of participant
Genetic Variation and Signatures of Natural Selection in Diverse Africans	phv00171014	Gender of participant
Genetic Variation and Signatures of Natural Selection in Diverse Africans	phv00171913	Gender of participant
Genetics Consortium for Late Onset of Alzheimer's Disease (LOAD CIDR Project)	phv00071843	Gender: male or female
Genetics Consortium for Late Onset of Alzheimer's Disease (LOAD CIDR Project)	phv00071861	Gender: male, female, or null children for pedigree structure
Genetics of High HDL Cholesterol	phv00171948	Gender of participant
Genetics of Human Developmental Brain Disorders	phv00168106	Gender of participant
Genetics of Inherited Muscle Disease	phv00195631	Gender of participant
Genetics of Inherited Muscle Disease	phv00220881	Gender of participant
Genetics of Lipid Lowering Drugs and Diet Network (GOLDN) Lipidomics Study	phv00202103	Gender of participant
Genetics of Neuropsychiatric and Neurodevelopmental Disorders	phv00196236	Gender of participant
Genetics of Schizophrenia in an Ashkenazi Jewish Case-Control Cohort	phv00165039	Gender of participant
GENEVA Genetics of Early Onset Stroke (GEOS) Study	phv00111930	Participant's gender
GENEVA: The Atherosclerosis Risk in Communities (ARIC) Study	phv00022834	Sex
Genome Sequencing of Hepatocellular Carcinoma	phv00218134	Gender of participant
Genome Sequencing of Pancreatic Ductal Adenocarcinoma	phv00171496	Gender of participant
Genome Variations Among the Aboriginals in Malaysia	phv00195915	Gender of participant
Genome Wide Association Study in Familial Crohn's Disease	phv00190278	Gender
Genome Wide Association Study in Familial Crohn's Disease	phv00190285	Gender of participant
Genome wide association study of 24 hour urine composition in the Nurses' Health Study, Nurses' Health Study II, and the Health Professionals Follow-Up Study	phv00165551	Gender of participant
Genome, Epigenome and RNA Sequences of MZ Twins Discordant for MS	phv00090329	Gender of participant
Genome-Wide Analysis of Chronic Lymphocytic Leukemia	phv00160276	Gender of participant
Genome-Wide Analysis of Hypodiploid ALL	phv00180571	Gender
Genome-Wide Association Studies in Upper Gastrointestinal Cancers (Asian)	phv00159417	Gender of participant [FEMALE, MALE]
Genome-Wide Association Study in Systemic Sclerosis	phv00161583	Subject's gender.
Genome-Wide Association Study of Amyotrophic Lateral Sclerosis in Finland	phv00158892	Gender of participant
Genome-Wide Association Study of Anorexia Nervosa	phv00196926	Gender
Genome-Wide Association Study of Beh+ºet's Disease (Turkish)	phv00124464	Subject gender
Genome-Wide Association Study of Celiac Disease	phv00091144	Gender of Participant
Genome-wide Association Study of Myasthenia Gravis	phv00200998	Gender of participant
Genome-Wide Association Study of Neuroblastoma	phv00158908	Gender of the subject [Female, Male, Unknown]
Genome-Wide Association Study of Relapse of Childhood Acute Lymphoblastic Leukemia	phv00196101	Male or female
Genome-Wide Association Study of Schizophrenia	phv00020112	Sex: male, female
Genome-Wide Association Study of Schizophrenia	phv00020235	Sex: male, female
Genome-Wide Association Study of Schizophrenia	phv00034892	Sex: male, female
Genome-Wide Association Study of Schizophrenia	phv00034926	Sex (male, female)
Genomic Analysis of Pediatric Low Grade Gliomas	phv00190510	Gender of participant
Genomic Characterization of Meningiomas	phv00174205	Gender of participant
Genomic Origins and Admixture in Latinos (GOAL)	phv00202272	Gender of participant
Genomic Predictors of Combat Stress Vulnerability and Resilience	phv00222718	Gender of participant
Genomic Sequencing of Cervical Cancers	phv00182022	Gender of participant
Genomic Sequencing of Colorectal Adenocarcinomas	phv00162707	Participant's gender as Male or Female
Genomic Sequencing of Pediatric Rhabdoid Cancers	phv00171414	Participant gender as male or female [Male, Female]
Genomic Sequencing of Pediatric Rhabdomyosarcoma	phv00201888	Patient gender
Genomic Sequencing of Solitary Fibrous Tumors	phv00179053	Gender of participant
Genomic Wide Scans for Female Osteoporosis Genes	phv00161534	Sex of study subject.
Genotype-Tissue Expression (GTEx)	phv00169062	Gender (Demography)
Genotyping 400 Samples from the NIGMS Human Variation Panels	phv00076466	Gender of participant
Genotyping NIGMS CEPH Samples from the United States, Venezuela, and France	phv00158856	Gender of participant
Genotyping NIGMS Chromosomal Aberration and Inherited Disorder Samples	phv00110716	Gender of participant
Ghana Prostate Study	phv00226956	Gender of participant
GWAS for Genetic Determinants of Bone Fragility	phv00065502	Gender of participant
GWAS in Fibrosing Interstitial Lung Disease	phv00201842	Gender of participant
GWAS of Breast Cancer in the African Diaspora	phv00172015	Gender of participant
GWAS of Familial Lung Cancer	phv00192256	Gender of participant
GWAS of Lung Cancer Susceptibility in Never-Smoking Women in Asia	phv00200111	Gender of participant [FEMALE, MALE]
GWAS on Cataract and HDL in the PMRP	phv00071870	Gender of participant
GWAS on Cataract and HDL in the PMRP	phv00077312	Gender of participant
Health and Retirement Study (HRS)	phv00167516	Gender of respondent
HeLa S3 (CCL-2.2) HiC Sequencing	phv00196373	Gender of participant [F]
Hepatitis C Antiviral Long-term Treatment Against Cirrhosis (HALT-C)	phv00174312	Gender
High Density SNP Association Analysis of Lung Cancer	phv00201874	Gender of participant [Male, Female]
High Density SNP Association Analysis of Melanoma	phv00073646	Patient's gender
HIV-Resistant People with Hemophilia	phv00165018	Gender of participant
HMP Core Microbiome Sampling Protocol A (HMP-A)	phv00158769	Gender
HMP Core Microbiome Sampling Protocol A (HMP-A)	phv00158770	Gender - coded fields
Human Autism Genetics and Activity Dependent Gene Activation	phv00226789	Gender of subject
Human Gut Microbiome in Amish Obesity	phv00090513	Gender of participant
Human Gut Microbiome in Crohn's Disease	phv00090580	Subject's gender
Human Responses to Influenza Vaccination	phv00217674	Sex of participant
Hypertriglyceridemia Study in Mexicans	phv00190652	Gender of participant
ICPCG Genome Wide Association Study of Familial Prostate Cancer	phv00201571	Gender of participant
Identification of Genes Involved in Familial Coronary Artery Disease	phv00171554	Gender of participant
Identification of Recurrent SMO and BRAF Mutations in Ameloblastomas	phv00201612	Sex of subject
IgA Nephropathy GWAS (IGANGWAS)	phv00218099	Gender of participant
IgA Nephropathy GWAS (IGANGWAS)	phv00164712	Gender of participant
Immunosenescence: Immunity in the Young and Aged	phv00217650	Gender of participant
Indianapolis-Ibadan, Nigeria Comparative Epidemiological Study of Dementia	phv00161465	Gender of subject
Integration of Genomics and Transcriptomics in unselected Twins and in Major Depression	phv00171371	Gender of participant
International Consortium on the Genetics of Heroin Dependence	phv00171329	Gender
International Consortium to Identify Genes and Interactions Controlling Oral Clefts	phv00088044	Individual's Gender
International Multi-Center ADHD Genetics Project	phv00011566	Gender of child
IPM BioBank GWAS	phv00162679	Gender of subject
Ischemic Stroke Genetics Study (ISGS)	phv00024265	Gender of the subject
Ischemic Stroke Genetics Study (ISGS)	phv00034499	Gender of participant (male or female)
Italian PBC Study	phv00168044	Gender of participant
Jackson Heart Study (JHS) Cohort	phv00172142	Gender of participant
Jackson Heart Study (JHS) Cohort	phv00125546	GENDER OF PARTICIPANT (M,F) Q18
Jackson Heart Study (JHS) Cohort	phv00125635	GENDER OF PARTICIPANT (M,F) Q18
Jackson Heart Study (JHS) Cohort	phv00125724	GENDER OF PARTICIPANT (M,F) Q18
Jackson Heart Study (JHS) Cohort	phv00125811	GENDER OF PARTICIPANT (M,F) Q18
Jackson Heart Study (JHS) Cohort	phv00126012	Gender of participant
Jackson Heart Study (JHS) Cohort	phv00127524	4: Participant's gender
Joint Genome-Wide Gene Expression and GWAS Mapping in the MGS Dataset	phv00202325	Gender of participant
L1-seq and genome-wide SNP genotyping in a multiethnic Asian population	phv00201446	Gender of participant
Longitudinal Genome-Wide Analysis of Patients with Chronic Lymphocytic Leukemia	phv00218111	Gender of participant
Mayo-Perlegen LEAPS (Linked Efforts to Accelerate Parkinson's Solutions) Collaboration	phv00020553	Gender, Tier1
Mayo-Perlegen LEAPS (Linked Efforts to Accelerate Parkinson's Solutions) Collaboration	phv00024092	Gender, Tier2
Medulloblastoma exome sequence analysis	phv00171448	Participant's gender as Male or Female
Megabase-scale Haplotyped Genomic Analysis of Normal and Cancer Genomes	phv00225801	Gender of participant
Melanoma Exome Sequencing	phv00226764	Gender of participant
Melanoma Genome Sequencing Project	phv00167383	Gender of patient [Male, Female]
Metabolism and Genetics of Hypobetalipoproteinemia	phv00174227	Gender of participant
Metagenomic Study of the Human Skin Microbiome Associated with Acne	phv00090394	Gender of participant
Methotrexate Clearance GWAS	phv00195886	Male or female
Minnesota Center for Twin and Family Research (MCTFR)	phv00201962	Gender of participant
miRNA profiles in serum and CSF of Parkinson's and Alzheimer's patients	phv00201810	Gender of participant
MitoExome Sequencing of Mitochondrial OXPHOS Diseases (MGH)	phv00156596	Gender of participant
Molecular Defects in Pseudohypoparathyroidism or Related Disorders	phv00167913	Gender of participant
Molecular Genetic Analysis of Inherited Kidney Dysfunction	phv00167971	Gender of participant
Molecular Genetics of Schizophrenia - nonGAIN Sample (MGS_nonGAIN)	phv00071338	Gender: male or female
Molecular Genetics of Schizophrenia - nonGAIN Sample (MGS_nonGAIN)	phv00071461	Gender where 1 = male, 2 = female
Molecular Profiling of Cancer	phv00165136	Gender of participant
Multi-Ethnic Study of Atherosclerosis (MESA) Cohort	phv00082643	GENDER
Multi-Ethnic Study of Atherosclerosis (MESA) Cohort	phv00084446	GENDER
Multi-Ethnic Study of Atherosclerosis (MESA) Cohort	phv00085782	GENDER
Multi-Ethnic Study of Atherosclerosis (MESA) Cohort	phv00086268	GENDER
Multi-Ethnic Study of Atherosclerosis (MESA) Cohort	phv00086736	GENDER
Multi-Ethnic Study of Atherosclerosis (MESA) Cohort	phv00087073	GENDER
Multi-Ethnic Study of Atherosclerosis (MESA) Cohort	phv00174586	GENDER
Multi-Ethnic Study of Atherosclerosis (MESA) Cohort	phv00175856	GENDER
Multi-Ethnic Study of Atherosclerosis (MESA) Cohort	phv00175877	GENDER
Multi-Ethnic Study of Atherosclerosis (MESA) Cohort	phv00175940	FAMILY COHORT: GENDER
Multi-Ethnic Study of Atherosclerosis (MESA) Cohort	phv00176009	GENDER
Multi-Ethnic Study of Atherosclerosis (MESA) Cohort	phv00219022	GENDER
Multiethnic Cohort (MEC) Breast Cancer Genetics	phv00173161	Gender
N.C. Clinical Genomic Evaluation by NextGen Exome Sequencing (NCGENES)	phv00222601	Gender of participant
NAB2-STAT6 Gene Fusions in Solitary Fibrous Tumor by Integrative Sequencing	phv00174514	Gender
National Cancer Institute (NCI) Cancer Genome Characterization Initiative (CGCI): HIV+ Tumor Molecular Characterization Project - Diffuse Large B-Cell Lymphoma (HTMCP - DLBCL)	phv00173789	Gender
National Cancer Institute (NCI) Cancer Genome Characterization Initiative (CGCI): HIV+ Tumor Molecular Characterization Project - Lung Cancer (HTMCP - LC)	phv00190993	Gender
National Cancer Institute (NCI) Cancer Genome Characterization Initiative (CGCI): Medulloblastoma	phv00173796	Gender
National Cancer Institute (NCI) Cancer Genome Characterization Initiative (CGCI): Non-Hodgkin Lymphoma	phv00173803	Gender
NCI Genome-Wide Association Study of Renal Cell Carcinoma	phv00159249	Gender of participant
NCI GWAS of Lung Cancer in Never Smokers	phv00201633	Gender of participant
NCI GWAS of Renal Cell Carcinoma in African Americans	phv00226593	Gender of participant [MALE, FEMALE]
NCI Non-Hodgkin Lymphoma GWAS	phv00225218	Gender of participant
NCI Non-Hodgkin Lymphoma GWAS	phv00225228	Gender of participant
NEI Ocular Hypertension Treatment Study (OHTS)	phv00160401	Gender of participant
NEIGHBOR Consortium Glaucoma GWAS	phv00129642	Gender 1: Male, 2: Female, 999: Missing
Neurodevelopmental Genomics: Trajectories of Complex Phenotypes	phv00194003	Gender of participant as identified by survey of patient/patient's parent
Neurodevelopmental Genomics: Trajectories of Complex Phenotypes	phv00194909	Subject's gender
Next Generation Mendelian Genetics: Auriculocondylar Syndrome (ACS)	phv00197289	Gender
Next Generation Mendelian Genetics: Auriculocondylar Syndrome (ACS)	phv00197294	Gender
Next Generation Mendelian Genetics: Ehlers-Danlos Syndrome Type VIII	phv00174271	Subject's gender
Next Generation Mendelian Genetics: Familial Hemophagocytic Lymphohistiocytosis	phv00174188	Gender of participant
Next Generation Mendelian Genetics: Hereditary Neurological Disorders	phv00200320	Gender
NGS in Advanced Cancers	phv00195642	Gender of participant
NHGRI Genome-Wide Association Study of Venous Thromboembolism (GWAS of VTE)	phv00121845	Gender
NHGRI Tumor Sequencing Project (Lung Adenocarcinoma)	phv00071771	Gender of participant
NHLBI Cleveland Family Study (CFS) Candidate Gene Association Resource (CARe)	phv00122007	Subject's gender
NHLBI Cleveland Family Study (CFS) Candidate Gene Association Resource (CARe)	phv00122989	Subject's Gender
NHLBI GO-ESP Family Studies: Pulmonary Arterial Hypertension	phv00191044	Gender
NHLBI GO-ESP: Family Studies (Aortic Disease)	phv00179491	Gender of participant
NHLBI GO-ESP: Family Studies (Atypical Cystic Fibrosis)	phv00179565	Gender of participant
NHLBI GO-ESP: Family Studies (Dilated Cardiomyopathy)	phv00181166	Gender of participant
NHLBI GO-ESP: Family Studies (Familial Interstitial Pneumonia)	phv00182046	Gender of participant
NHLBI GO-ESP: Family Studies (Hematological Cancers)	phv00196142	Gender of participant
NHLBI GO-ESP: Family Studies (Mendelian Lipid Disorders)	phv00195790	Gender of participant
NHLBI GO-ESP: Family Studies: (Familial Atrial Fibrillation)	phv00181914	Gender of participant
NHLBI GO-ESP: Heart Cohorts Exome Sequencing Project (ARIC)	phv00190418	Values: Male; Female
NHLBI GO-ESP: Heart Cohorts Exome Sequencing Project (ISGS)	phv00179584	Values: Male; Female
NHLBI GO-ESP: Heart Cohorts Exome Sequencing Project (SWISS)	phv00174111	GENDER OF PARTICIPANT
NHLBI GO-ESP: Lung Cohorts Exome Sequencing Project (Asthma)	phv00181856	Gender of participant
NHLBI GO-ESP: Lung Cohorts Exome Sequencing Project (Cystic Fibrosis)	phv00159434	Gender of participant.
NHLBI GO-ESP: Lung Cohorts Exome Sequencing Project (Cystic Fibrosis)	phv00159440	Gender of participant.
NHLBI GO-ESP: Women's Health Initiative Exome Sequencing Project (WHI) - WHISP	phv00161367	GENDER OF PARTICIPANT
NIA - Late Onset Alzheimer's Disease and National Cell Repository for Alzheimer's Disease Family Study: Genome-Wide Association Study for Susceptibility Loci	phv00071268	Gender: male or female
NIA - Late Onset Alzheimer's Disease and National Cell Repository for Alzheimer's Disease Family Study: Genome-Wide Association Study for Susceptibility Loci	phv00071321	Gender: male, female, or null (children for pedigree structure)
NIA Long Life Family Study (LLFS)	phv00163237	Gender
NIDCR Sjogren's International Collaborative Clinical Alliance (SICCA)	phv00226846	Gender of participant
NIDDK Drug-Induced Liver Injury Network (DILIN)	phv00195956	Gender
NIDDK Gene discovery in FSGS	phv00202568	Gender of participant
NIDDK Gene discovery in VUR	phv00202545	Gender of participant
NIDDK Genetics of Metabolic Syndrome in an Island Population	phv00222296	Sex
NIDDK Genetics of Metabolic Syndrome in an Island Population	phv00222305	Sex
NIH Exome Sequencing of Familial Amyotrophic Lateral Sclerosis Project	phv00200477	Gender of participant
NIH Exome Sequencing of Familial Amyotrophic Lateral Sclerosis Project	phv00088181	Gender of participant
NIH Exome Sequencing of Familial Amyotrophic Lateral Sclerosis Project	phv00158872	Gender of participant
NIH Exome Sequencing of Familial Amyotrophic Lateral Sclerosis Project	phv00024103	Subject's gender
NIH Exome Sequencing of Familial Amyotrophic Lateral Sclerosis Project	phv00024162	Subject's gender
NINDS Parkinson's Disease	phv00023939	Gender of the subject
NINDS Parkinson's Disease	phv00024005	Gender of the subject
NINDS Parkinsonism Study	phv00000187	Gender of the subject
NINDS Repository Cerebrovascular Disease/Stroke Study	phv00024079	Gender of the subject
NINDS Repository Motor Neuron Disease/ALS Study	phv00020520	Gender of the subject
NINDS Repository Neurologically Normal Control Collection	phv00000225	Gender of the subject
NINDS Stroke Genetics Network (SiGN)	phv00190672	Self reported gender
Northwestern NUgene Project: Type 2 Diabetes	phv00158808	Gender of participant
Northwestern NUgene Project: Type 2 Diabetes	phv00158818	Gender
OMRF SLEGEN GWAS Data from European-American Women with Lupus	phv00076097	Gender of subject
Oncogenomics of Malignant Peripheral Nerve Sheath Tumors	phv00217577	Gender of participant
Osteosarcoma Genome-wide Association Study	phv00200964	Gender of participant [FEMALE, MALE]
Osteosarcoma Genomics	phv00220907	Gender of patient
PAGE: Epidemiologic Architecture for Genes Linked to Environment (EAGLE) - BioVU Cancer Project	phv00196394	Gender of participant
PAGE: Multiethnic Cohort (MEC)	phv00163089	Gender
Paired AML Epigenetics Study on Clonality	phv00202812	Gender of participant
Pancreatic Cancer Case-Control Association Study	phv00226238	Gender
Pancreatic Cancer Cohort and Case-Control Consortium (PanScan)	phv00076258	Gender of the participant
Pediatric Cardiac Genetics Consortium (PCGC)	phv00191088	Subject's gender
PGC: the PUWMa GWAS of ADHD	phv00159878	Gender of participant
PGRN Antidepressant Medication Pharmacogenomic Study (AMPS)	phv00195982	Gender
PGRN-RIKEN: Identification of Genetic Predictors of ACE Inhibitor-Associated Angioedema	phv00190844	Gender
PGRN-RIKEN: Rate Control Therapy in Patients with Atrial Fibrillation	phv00173383	Gender of participant
Pharmacogenomics of Anti-Platelet Intervention (PAPI) Study	phv00173925	Gender of participant
Pilocytic Astrocytoma in NF1	phv00174531	Gender of participant
POLYGEN	phv00160468	Gender of participant
POLYGEN	phv00160479	Gender of participant
POPRES: Population Reference Sample	phv00066614	Gender used by POPRES. Reported if exists, else inferred from sex linked data if successfully genotyped.
PREDICT-HD Huntington Disease Study	phv00172057	Gender
Primary ER-positive Breast Cancer Treated with Neoadjuvant Letrozole	phv00222697	Gender of participant
Prostate Cancer Genome Sequencing Project	phv00167303	Gender of participant [Male, Female]
RAD50 Hypomorphism as Basis for Response to Chemotherapy	phv00197161	Gender
Rapid Whole Genome Sequencing for Genetic Disease Diagnosis in the NICU	phv00174357	Gender of participant
Rare Mendelian Disease in Old Order Amish and Mennonite Patients	phv00190988	Participant's gender as Male or Female
Resistance studies in Lung Cancer	phv00224917	Gender of participant
Resource for Genetic Epidemiology Research on Aging (GERA)	phv00196838	Gender
Responses to Varicella Zoster Virus Vaccination	phv00221173	Sex
Responses to Varicella Zoster Virus Vaccination	phv00221179	Gender of participant
Retrotransposition in Colorectal Cancer	phv00173541	Gender of participant
Risk Assessment of Cerebrovascular Events (RACE) Study	phv00167701	Subject's gender
RM Epigenomics Program - Broad_Alz_and_Age-Related	phv00191101	Gender of participant
RNA-Seq studies of Gene Expression in Cells and Networks in FI and ACC in Autism	phv00190495	Gender of participant
RNAseq analysis of posterior cingulate astrocytes in Alzheimer's disease	phv00201726	Gender of participant
San Francisco Bay Area Latina Breast Cancer Study	phv00226550	Gender of participant
SardiNIA Medical Sequencing Discovery Project	phv00141809	Gender of individual
SardiNIA Medical Sequencing Discovery Project	phv00141813	Gender of individual
Search for Susceptibility Genes for Diabetic Nephropathy in Type 1 Diabetes (GoKinD study participants and parents), NIDDK	phv00020794	Participant's gender - See also GAIN - GoKinD phs000018: SEX
Search for Susceptibility Genes for Diabetic Nephropathy in Type 1 Diabetes (GoKinD study participants), GAIN	phv00019965	Participant's gender - See also NIDDK - GoKinD phs000088: SEX
Sensitivity to the subjective effects of amphetamine	phv00221225	Gender of participant
Sequence Analysis of Mutations and Translocations Across Breast Cancer Subtypes	phv00167357	Participant's gender as male or female [Male, Female]
Sequencing of ETP T-ALL	phv00159267	Gender
Sequencing of Medulloblastoma	phv00169041	Gender
Sequencing of Retinoblastoma	phv00160438	Gender
Sequencing of Targeted Genomic Regions Associated with Smoking	phv00217965	Participant gender
Shanghai Breast Cancer Genetics Study (SBCGS)	phv00217898	Gender of participant [female, male]
Single Cell Analysis Program - Transcriptome (SCAP-T)	phv00219205	Gender of the subject
Skin Microbiome in Disease States: Atopic Dermatitis and Immunodeficiency	phv00090676	Gender of participant
Small Intestine Neuroendocrine Tumors (Carcinoid Tumors)	phv00190468	Participant's gender as Male or Female
SNP Health Association Resource (SHARe) Asthma Resource Project (SHARP)	phv00070936	Gender of participant
SNP Health Association Resource (SHARe) Asthma Resource Project (SHARP)	phv00070997	Gender of participant
SNP Health Association Resource (SHARe) Asthma Resource Project (SHARP)	phv00071047	Gender of participant
SNP Health Association Resource (SHARe) Asthma Resource Project (SHARP)	phv00071105	Gender of participant
SNP Health Association Resource (SHARe) Asthma Resource Project (SHARP)	phv00071155	Gender of participant
SNP Health Association Resource (SHARe) Asthma Resource Project (SHARP)	phv00071213	Gender of participant
SNP Health Association Resource (SHARe) Asthma Resource Project (SHARP)	phv00071823	Gender
Somatic Mutations in Variant and IGHV4-34 Expressing Hairy Cell Leukemia	phv00195931	Gender of participant
Spatiotemporal Transcriptome of the Human Brain	phv00163221	Gender of subjects
Spectrum of Mutations in Myeloid Neoplasms	phv00202080	Gender of participant
Sporadic Amyotrophic Lateral Sclerosis (ALS): Sequencing Study	phv00252380	Biological gender of subject
STAMPEED: Northern Finland Birth Cohort 1966 (NFBC1966)	phv00129605	Gender of participant
Strabismus, CCDD and Other Anomalies	phv00167779	Gender of participant
Strong Activation of Retroviral LTRs in HCC	phv00225166	Gender of participant
Study of Adaptation to Hypoxia in Ethiopian Highlanders	phv00195533	Gender of participant
Study of Addiction: Genetics and Environment (SAGE)	phv00022888	Participant's gender
Study of Irish Amyotrophic Lateral Sclerosis (SIALS)	phv00066544	Participant's gender
Study of Irish Amyotrophic Lateral Sclerosis (SIALS)	phv00066550	Participant's gender
Study of Melanoma Risk in Australia and the United Kingdom	phv00182063	Gender
Sweden-Schizophrenia Population-Based Case-Control Exome Sequencing	phv00167461	Gender of participant
TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2	phv00167582	Gender
TARGET: Acute Lymphoblastic Leukemia (ALL) Pilot Phase 1	phv00167559	Gender
TARGET: Acute Myeloid Leukemia (AML)	phv00167605	Gender
TARGET: Cancer Model Systems (MDLS): Cell Lines and Xenografts (including PPTP)	phv00167654	Gender
TARGET: Kidney, Clear Cell Sarcoma of the Kidney (CCSK)	phv00167612	Gender
TARGET: Kidney, Rhabdoid Tumor (RT)	phv00167661	Gender
TARGET: Kidney, Wilms Tumor (WT)	phv00167668	Gender
TARGET: Neuroblastoma (NBL)	phv00167620	Gender
TARGET: Osteosarcoma (OS)	phv00167647	Gender
Targeted Sequencing of GWAS Loci in Cleft Lip and Palate	phv00201753	Gender of participant
Temporal Dissection of Tumorigenesis in Primary Cancers	phv00167535	Gender
The Collaborative Study on the Genetics of Alcoholism (COGA)	phv00217592	Gender Status
The Collaborative Study on the Genetics of Alcoholism (COGA)	phv00217635	Gender Status
The Detroit Neighborhood Health Study (DNHS)	phv00174401	Gender of participant.
The Familial Intracranial Aneurysm Linkage Study (FIA)	phv00191116	Gender
The Familial Intracranial Aneurysm Linkage Study (FIA)	phv00191121	Gender
The Finland-United States Investigation of NIDDM Genetics (FUSION) - GWAS Study	phv00087897	Gender of participant
The Gene Partnership (TGP) - eMERGE Data	phv00171962	Gender of Subject - as reported by participant
The Gene Partnership (TGP) - eMERGE Data	phv00172003	Gender of sample - as indicated by genotype analysis
The Genetic Architecture of Smoking and Smoking Cessation	phv00162801	Participant's gender
The Genetic Architecture of Smoking and Smoking Cessation	phv00162918	Participant's gender
The Genetic Landscape of Mutations in Burkitt Lymphoma	phv00178124	Gender of participant
The Genomic Complexity of Primary Human Prostate Cancer	phv00154533	Gender of participant
The Genomics and Randomized Trials Network (GARNET) Vitamin Intervention Stroke Prevention (VISP) trial	phv00159330	Gender (male, female)
The Glaucoma Genes and Environment (GLAUGEN) Study	phv00142513	NHS/HPFS/GEP: Gender
The Human Gut Microbiome and Recurrent Abdominal Pain in Children	phv00091112	Gender of participant
The Human Virome and Febrile Illness in Children	phv00098405	Gender of participant
The Molecular Basis of Inherited Reproductive Disorders	phv00167992	Gender of participant
The mutational characterization of adenoid cystic carcinoma	phv00195824	Gender of the participate
The Mutational Landscape of Head and Neck Squamous Cell Carcinoma	phv00163064	Participant's gender [Male, Female]
The Neonatal Microbiome and NEC	phv00091251	Sex of subject
The Neonatal Microbiome and NEC	phv00091258	Sex of subject
The Role of the Gut Microbiota in Ulcerative Colitis	phv00091161	Gender
The UC San Diego Chronic Lymphocytic Leukemia (CLL) Study	phv00202243	Gender of participant
Towards a Genomic Understanding of Myeloma	phv00159451	Participant's gender as Male or Female
Transcriptome Sequencing of Pediatric AML FAB-M7	phv00174237	Gender
Treatment of Genetic Screening of Hypertriglyceridemia type I, III, and V - HTG Amsterdam	phv00171438	Gender of participant
Type 1 Diabetes Genetics Consortium (T1DGC): Copy Number Variant (CNV) Study	phv00226507	Gender of participant
Type 2 Diabetes in African Americans, GWAS and Exome Sequencing	phv00066340	Gender of participant has been confirmed with genotyping: 1 = Male, 2 = Female
Type 2 Diabetes in African Americans, GWAS and Exome Sequencing	phv00066354	Gender of participant has been confirmed with genotyping: 1 = Male, 2 = Female
Type 2 Diabetes Starr County GWAS and Exome Sequencing	phv00066507	Gender
Tyrosine Kinase Mutations in Endometrial Cancer	phv00221198	Gender of participant
University of Miami Study on Genetics of Autism and Related Disorders (AutismDisorders)	phv00171540	Gender of participant
University of Michigan Clinical Sequencing Exploratory Research (CSER)	phv00197132	Gender of participant
University of Washington Center for Mendelian Genomics (UW-CMG)	phv00197223	Subject's sex
University of Washington Center for Mendelian Genomics (UW-CMG)	phv00197228	Subject's sex
University of Washington CSF biomarker study for Parkinson disease	phv00225944	Gender of participant
Vanderbilt Genome-Electronic Records (VGER) Project: QRS Duration	phv00077277	Gender of participant
VESPA: Genome Wide Study of Vancomycin	phv00225885	Gender of participant
VitGene Generalized Vitiligo Genetics Study	phv00158991	Gender of participant
Whole Exome and Targeted Sequencing in Tourette Syndrome Multiplex Families	phv00163339	Gender of participant
Whole Exome and Transcriptome Sequencing in Sporadic ALS	phv00201705	Gender of participant
Whole Exome Sequence of Hearing Loss Family	phv00252647	Gender of participant
Whole Exome Sequencing for Colorectal Cancer	phv00163736	Gender of participant
Whole Exome Sequencing for Familial Intracranial Aneurysm (FIA I-II) Study	phv00193922	Gender
Whole Exome Sequencing for Familial Intracranial Aneurysm (FIA I-II) Study	phv00193929	Gender
Whole Exome Sequencing of Chronic Lymphocytic Leukemia	phv00165095	Participant's gender as Male or Female.
Whole Exome Sequencing of Diffuse Large B-Cell Lymphoma	phv00165116	Participant's gender [Male or Female]
Whole Genome Association Study of Bipolar Disorder	phv00011576	A1. Sex. (Participants with European ancestry). DIGS2
Whole Genome Association Study of Bipolar Disorder	phv00016991	A1. Gender. INTERVIEWER: circle sex code. (Participants with European ancestry). DIGS4
Whole Genome Association Study of Bipolar Disorder	phv00035052	Sex: male, female. (Participants with European ancestry)
Whole Genome Association Study of Bipolar Disorder	phv00035338	Sex: male or female, (Participants with European ancestry). DIGS3
Whole Genome Association Study of Bipolar Disorder	phv00051908	A1 Gender, (African American participants). DIGS4
Whole Genome Association Study of Bipolar Disorder	phv00054360	Sex: male, female. (African American participants)
Whole Genome Association Study of Systemic Lupus Erythematosus	phv00066360	Gender
Whole Genome Association Study of Visceral Adiposity in the HABC Study	phv00071826	Gender
Whole Genome Association Twin Study of Myopia and Glaucoma Risk Factors	phv00066468	Gender of participant
Whole Genome Comparisons of Breast Cancers and their Xenotransplants	phv00195712	Subject's gender
Whole Genome Profiling to Detect Schizophrenia Methylation Markers	phv00191011	Gender status
Whole Genome Sequencing of Triple Negative Breast Cancer	phv00124471	Gender of participant
Whole Genome Sequencing of Two 22q11DS Trios	phv00222265	Gender of participant
Whole-Genome and Exome Sequencing in Clear-Cell Renal Cell Carcinoma	phv00168012	Gender of participant
Whole-genome sequencing in multiplex epilepsy families	phv00196481	Self-declared gender of participant
Whole-Genome Sequencing of Acute Myeloid Leukemia	phv00073670	Gender of participant
XPC and Non-XPC Cutaneous Squamous Cell Carcinoma Mutation Rate Study	phv00252611	Gender of participant
Yale Center for Mendelian Genomics (Y CMG)	phv00202582	Subject's gender
Yale Center for Mendelian Genomics (Y CMG)	phv00202587	Subject's gender

Mapping for PX161201_Main_Presenting_Symptoms_Fatigue

dbGAP Study	dbGAP Variable	dbGAP Variable Description
Cardiovascular Health Study (CHS) Cohort	phv00099129	PRESENT FATIGUE
Cardiovascular Health Study (CHS) Cohort	phv00106117	PRESENT FATIGUE

Mapping for PX161201_Main_Presenting_Symptoms_Fever

dbGAP Study	dbGAP Variable	dbGAP Variable Description
Cardiovascular Health Study (CHS) Cohort	phv00099141	PRESENT FEVER
Cardiovascular Health Study (CHS) Cohort	phv00099142	INCREASE IN FEVER
Cardiovascular Health Study (CHS) Cohort	phv00106127	PRESENT FEVER
Cardiovascular Health Study (CHS) Cohort	phv00106128	INCREASE IN FEVER

Mapping for PX161201_Main_Presenting_Symptoms_Genitourinary

dbGAP Study	dbGAP Variable	dbGAP Variable Description
Pediatric Cardiac Genetics Consortium (PCGC)	phv00180874	Genitourinary abnormalities present

Mapping for PX161201_Main_Presenting_Symptoms_HEENT

dbGAP Study	dbGAP Variable	dbGAP Variable Description
HMP Core Microbiome Sampling Protocol A (HMP-A)	phv00158683	HEENT
HMP Core Microbiome Sampling Protocol A (HMP-A)	phv00158704	HEENT

Mapping for PX161201_Main_Presenting_Symptoms_Lymphatic

dbGAP Study	dbGAP Variable	dbGAP Variable Description
DCCT-EDIC Clinical Trial and Follow-up of Persons with Type 1 Diabetes	phv00034429	Abnormality of lymphatic system

Mapping for PX161201_Main_Presenting_Symptoms_Musculoskeletal

dbGAP Study	dbGAP Variable	dbGAP Variable Description
HMP Core Microbiome Sampling Protocol A (HMP-A)	phv00158698	Musculoskeletal
HMP Core Microbiome Sampling Protocol A (HMP-A)	phv00158731	Musculoskeletal

Mapping for PX161201_Main_Presenting_Symptoms_Neurologic

dbGAP Study	dbGAP Variable	dbGAP Variable Description
HMP Core Microbiome Sampling Protocol A (HMP-A)	phv00158722	Neurologic

Mapping for PX161201_Patient_Type

dbGAP Study	dbGAP Variable	dbGAP Variable Description
Hepatitis C Antiviral Long-term Treatment Against Cirrhosis (HALT-C)	phv00174335	Patient type: SVR (negative wk72)
Hepatitis C Antiviral Long-term Treatment Against Cirrhosis (HALT-C)	phv00174336	Patient type: breakthrough
Hepatitis C Antiviral Long-term Treatment Against Cirrhosis (HALT-C)	phv00174337	Patient type: relapse

Protocol - International Travel History

Essential Protocols:

Description

Specific Instructions

Availability

Protocol

Personnel and Training Required

Equipment Needs

Requirements

Mode of Administration

Lifestage

Participants

Selection Rationale

Language

Standards

Derived Variables

Process and Review

Protocol Name from Source

Source

General References

Protocol ID

Variables

Measure Name

Release Date

Definition

Purpose

Keywords

Measure Protocols

Publications